<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id><journal-id journal-id-type="pmc-domain-id">670</journal-id><journal-id journal-id-type="pmc-domain">frontneurosci</journal-id><journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id><journal-title-group><journal-title>Frontiers in Neuroscience</journal-title></journal-title-group><issn pub-type="ppub">1662-4548</issn><issn pub-type="epub">1662-453X</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC9693722</article-id><article-id pub-id-type="pmcid-ver">PMC9693722.1</article-id><article-id pub-id-type="pmcaid">9693722</article-id><article-id pub-id-type="pmcaiid">9693722</article-id><article-id pub-id-type="pmid">36440281</article-id><article-id pub-id-type="doi">10.3389/fnins.2022.1051038</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Neuroscience</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Peak width of skeletonized mean diffusivity in cerebral amyloid angiopathy: Spatial signature, cognitive, and neuroimaging associations</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Zanon Zotin</surname><given-names initials="MC">Maria Clara</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/845434/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schoemaker</surname><given-names initials="D">Dorothee</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/874623/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Raposo</surname><given-names initials="N">Nicolas</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/620707/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Perosa</surname><given-names initials="V">Valentina</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bretzner</surname><given-names initials="M">Martin</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/1436278/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sveikata</surname><given-names initials="L">Lukas</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref><xref rid="aff8" ref-type="aff">
<sup>8</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/245241/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="Q">Qi</given-names></name><xref rid="aff9" ref-type="aff">
<sup>9</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/609077/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>van Veluw</surname><given-names initials="SJ">Susanne J.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/614886/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Horn</surname><given-names initials="MJ">Mitchell J.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/2050413/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Etherton</surname><given-names initials="MR">Mark R.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/429945/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Charidimou</surname><given-names initials="A">Andreas</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff10" ref-type="aff">
<sup>10</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/54889/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gurol</surname><given-names initials="ME">M. Edip</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Greenberg</surname><given-names initials="SM">Steven M.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Duering</surname><given-names initials="M">Marco</given-names></name><xref rid="aff11" ref-type="aff">
<sup>11</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>dos Santos</surname><given-names initials="AC">Antonio Carlos</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/1770474/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pontes-Neto</surname><given-names initials="OM">Octavio M.</given-names></name><xref rid="aff12" ref-type="aff">
<sup>12</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/413231/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Viswanathan</surname><given-names initials="A">Anand</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/405023/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>J. Philip Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country></aff><aff id="aff2"><sup>2</sup><institution>Center for Imaging Sciences and Medical Physics, Department of Medical Imaging, Hematology and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo</institution>, <addr-line>Ribeirão Preto</addr-line>, <country>Brazil</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country></aff><aff id="aff4"><sup>4</sup><institution>Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS</institution>, <addr-line>Toulouse</addr-line>, <country>France</country></aff><aff id="aff5"><sup>5</sup><institution>German Center for Neurodegenerative Disease</institution>, <addr-line>Magdeburg</addr-line>, <country>Germany</country></aff><aff id="aff6"><sup>6</sup><institution>University of Lille, Inserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neurosciences &amp; Cognition</institution>, <addr-line>Lille</addr-line>, <country>France</country></aff><aff id="aff7"><sup>7</sup><institution>Division of Neurology, Department of Clinical Neurosciences, Geneva University Hospitals</institution>, <addr-line>Geneva</addr-line>, <country>Switzerland</country></aff><aff id="aff8"><sup>8</sup><institution>Institute of Cardiology, Medical Academy, Lithuanian University of Health Sciences</institution>, <addr-line>Kaunas</addr-line>, <country>Lithuania</country></aff><aff id="aff9"><sup>9</sup><institution>The First Affiliated Hospital of Chongqing Medical University</institution>, <addr-line>Chongqing</addr-line>, <country>China</country></aff><aff id="aff10"><sup>10</sup><institution>Department of Neurology, Boston University School of Medicine, Boston University Medical Center</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country></aff><aff id="aff11"><sup>11</sup><institution>Department of Biomedical Engineering, Medical Imaging Analysis Center (MIAC), University of Basel</institution>, <addr-line>Basel</addr-line>, <country>Switzerland</country></aff><aff id="aff12"><sup>12</sup><institution>Department of Neuroscience and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo</institution>, <addr-line>Ribeirão Preto</addr-line>, <country>Brazil</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Marek Joukal, Masaryk University, Czechia</p></fn><fn fn-type="edited-by"><p>Reviewed by: Cheryl R. McCreary, University of Calgary, Canada; Ami Tsuchida, Université de Bordeaux, France</p></fn><corresp id="c001">*Correspondence: Maria Clara Zanon Zotin, <email>mzanonzotin@mgh.harvard.edu</email>, <email>mczzotin@hcrp.usp.br</email></corresp><fn fn-type="other" id="fn004"><p>This article was submitted to Brain Imaging Methods, a section of the journal Frontiers in Neuroscience</p></fn></author-notes><pub-date pub-type="epub"><day>11</day><month>11</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>16</volume><issue-id pub-id-type="pmc-issue-id">400453</issue-id><elocation-id>1051038</elocation-id><history><date date-type="received"><day>22</day><month>9</month><year>2022</year></date><date date-type="accepted"><day>25</day><month>10</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>26</day><month>11</month><year>2022</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-28 02:25:28.697"><day>28</day><month>06</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright © 2022 Zanon Zotin, Schoemaker, Raposo, Perosa, Bretzner, Sveikata, Li, van Veluw, Horn, Etherton, Charidimou, Gurol, Greenberg, Duering, Santos, Pontes-Neto and Viswanathan.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Zanon Zotin, Schoemaker, Raposo, Perosa, Bretzner, Sveikata, Li, van Veluw, Horn, Etherton, Charidimou, Gurol, Greenberg, Duering, Santos, Pontes-Neto and Viswanathan</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fnins-16-1051038.pdf"/><abstract><sec><title>Background</title><p>Peak width of skeletonized mean diffusivity (PSMD) is a promising diffusion tensor imaging (DTI) marker that shows consistent and strong cognitive associations in the context of different cerebral small vessel diseases (cSVD).</p></sec><sec><title>Purpose</title><p>Investigate whether PSMD (1) is higher in patients with Cerebral Amyloid Angiopathy (CAA) than those with arteriolosclerosis; (2) can capture the anteroposterior distribution of CAA-related abnormalities; (3) shows similar neuroimaging and cognitive associations in comparison to other classical DTI markers, such as average mean diffusivity (MD) and fractional anisotropy (FA).</p></sec><sec><title>Materials and methods</title><p>We analyzed cross-sectional neuroimaging and neuropsychological data from 90 non-demented memory-clinic subjects from a single center. Based on MRI findings, we classified them into probable-CAA (those that fulfilled the modified Boston criteria), subjects with MRI markers of cSVD not attributable to CAA (presumed arteriolosclerosis; cSVD), and subjects without evidence of cSVD on MRI (non-cSVD). We compared total and lobe-specific (frontal and occipital) DTI metrics values across the groups. We used linear regression models to investigate how PSMD, MD, and FA correlate with conventional neuroimaging markers of cSVD and cognitive scores in CAA.</p></sec><sec><title>Results</title><p>PSMD was comparable in probable-CAA (median 4.06 × 10<sup>–4</sup> mm<sup>2</sup>/s) and cSVD (4.07 × 10<sup>–4</sup> mm<sup>2</sup>/s) patients, but higher than in non-cSVD (3.30 × 10<sup>–4</sup> mm<sup>2</sup>/s; <italic toggle="yes">p</italic> &lt; 0.001) subjects. Occipital-frontal PSMD gradients were higher in probable-CAA patients, and we observed a significant interaction between diagnosis and region on PSMD values [<italic toggle="yes">F</italic>(2, 87) = 3.887, <italic toggle="yes">p</italic> = 0.024]. PSMD was mainly associated with white matter hyperintensity volume, whereas MD and FA were also associated with other markers, especially with the burden of perivascular spaces. PSMD correlated with worse executive function (β = −0.581, <italic toggle="yes">p</italic> &lt; 0.001) and processing speed (β = −0.463, <italic toggle="yes">p</italic> = 0.003), explaining more variance than other MRI markers. MD and FA were not associated with performance in any cognitive domain.</p></sec><sec><title>Conclusion</title><p>PSMD is a promising biomarker of cognitive impairment in CAA that outperforms other conventional and DTI-based neuroimaging markers. Although global PSMD is similarly increased in different forms of cSVD, PSMD’s spatial variations could potentially provide insights into the predominant type of underlying microvascular pathology.</p></sec></abstract><kwd-group><kwd>cerebral amyloid angiopathy</kwd><kwd>cerebral small vessel disease</kwd><kwd>dementia</kwd><kwd>vascular cognitive impairment</kwd><kwd>diffusion tensor imaging</kwd><kwd>diffusion-weighted imaging</kwd></kwd-group><funding-group><award-group><funding-source id="cn001"><institution-wrap><institution>National Institutes of Health</institution><institution-id institution-id-type="doi">10.13039/100000002</institution-id></institution-wrap></funding-source><award-id award-type="contract" rid="cn001">R01AG047975</award-id><award-id award-type="contract" rid="cn001">R01AG026484</award-id><award-id award-type="contract" rid="cn001">P50AG005134</award-id><award-id award-type="contract" rid="cn001">K23AG02872605</award-id></award-group></funding-group><counts><fig-count count="3"/><table-count count="1"/><equation-count count="0"/><ref-count count="58"/><page-count count="13"/><word-count count="8867"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="S1"><title>Introduction</title><p>Cerebral amyloid angiopathy (CAA) is a form of cerebral small vessel disease (cSVD) related to the deposition of amyloid-beta around cortical and leptomeningeal vessels (<xref rid="B51" ref-type="bibr">Viswanathan and Greenberg, 2011</xref>). CAA is highly prevalent among older individuals and impacts cognition independently from commonly co-occurring Alzheimer’s disease (AD) (<xref rid="B2" ref-type="bibr">Arvanitakis et al., 2011</xref>). CAA has thus emerged as an important vascular contributor to cognitive impairment and dementia (VCID), even in the absence of intracerebral hemorrhage (ICH) (<xref rid="B57" ref-type="bibr">Xiong et al., 2017</xref>).</p><p>In order to facilitate the future development of disease-modifying therapies for VCID, it has become paramount to validate neuroimaging markers able to quantify the widespread parenchymal injury associated with cSVD (<xref rid="B38" ref-type="bibr">Smith et al., 2019</xref>). Among the many MRI markers available, those based on diffusion tensor imaging (DTI) provide more consistent cognitive associations due to their continuous quantitative nature and higher sensitivity to microstructural abnormalities (<xref rid="B37" ref-type="bibr">Smith and Beaudin, 2018</xref>).</p><p>A novel DTI marker called peak width of skeletonized mean diffusivity (PSMD) is considered particularly promising in the field of VCID (<xref rid="B4" ref-type="bibr">Baykara et al., 2016</xref>). PSMD is a fully automated histogram marker that reflects the heterogeneity of the mean diffusivity (MD) values across the main white matter (WM) tracts. It was developed to quantify the WM injury related to VCID and has provided consistent cognitive associations in several populations, especially among cohorts with cSVD (<xref rid="B4" ref-type="bibr">Baykara et al., 2016</xref>; <xref rid="B11" ref-type="bibr">Deary et al., 2019</xref>; <xref rid="B20" ref-type="bibr">Lam et al., 2019</xref>; <xref rid="B55" ref-type="bibr">Wei et al., 2019</xref>; <xref rid="B23" ref-type="bibr">Low et al., 2020</xref>; <xref rid="B25" ref-type="bibr">McCreary et al., 2020</xref>; <xref rid="B29" ref-type="bibr">Raposo et al., 2021</xref>). According to previous data, PSMD correlates with processing speed scores in CAA samples and could become a relevant marker for CAA-related cognitive impairment (<xref rid="B25" ref-type="bibr">McCreary et al., 2020</xref>; <xref rid="B29" ref-type="bibr">Raposo et al., 2021</xref>).</p><p>However, several questions concerning the utility of this marker in the field of CAA remain unanswered. In general, PSMD values found in samples with cSVD are higher than those with predominantly neurodegenerative pathology. However, it remains unknown whether PSMD values vary significantly across different forms of sporadic cSVD. Regional analyses with PSMD are thought to be feasible (<xref rid="B5" ref-type="bibr">Beaudet et al., 2020</xref>), and lobe-specific PSMD values have been successfully computed in a previous study (<xref rid="B23" ref-type="bibr">Low et al., 2020</xref>). However, no studies to date have investigated spatial variations in PSMD values in the context of CAA. Specifically, it is unknown whether PSMD could capture the posterior predominance of CAA pathology, like other diffusion techniques (<xref rid="B30" ref-type="bibr">Reijmer et al., 2015a</xref>). Furthermore, only one study in CAA has compared PSMD with other classical DTI markers in terms of cognitive and neuroimaging associations (<xref rid="B25" ref-type="bibr">McCreary et al., 2020</xref>), but the extent to which this new marker outperforms MD and fractional anisotropy (FA) remains uncertain.</p><p>In this context, our aims were: (1) to compare PSMD values in different MRI phenotypes of sporadic cSVDs and in subjects without evidence of cSVD on MRI; (2) to investigate whether the posterior predominance of CAA pathology is reflected on regional variations of PSMD values; (3) to investigate PSMD’s cognitive and neuroimaging associations in CAA, compared to other DTI-based MRI markers.</p></sec><sec sec-type="materials|methods" id="S2"><title>Materials and methods</title><sec id="S2.SS1"><title>Study participants</title><p>This study is a retrospective analysis of an ongoing single-center prospective memory-clinic research cohort from the MGH. Subjects were recruited between August 2010 and November 2019.</p><p>We included non-demented subjects aged 55 years or more with complete clinical evaluation, neuropsychological examination, and 3 T MRI. Exclusion criteria were: dementia (defined as Mini Mental State Examination [MMSE] ≤ 24 and/or impairment of independent activities of daily living [IADs]); a history of symptomatic intracerebral hemorrhage (ICH); incomplete neuropsychological examination and/or research MRI; and presence of motion or other artifacts compromising neuroimaging assessment. To avoid diagnostic uncertainty, we also excluded subjects with a single hemorrhagic MRI marker fulfilling the modified Boston criteria (<xref rid="B22" ref-type="bibr">Linn et al., 2010</xref>) for possible-CAA and those with mixed-pattern of hemorrhages (<xref rid="B27" ref-type="bibr">Pasi et al., 2018</xref>). Based on the examination of MR images for conventional neuroimaging markers of cSVD, and according to the modified Boston criteria (<xref rid="B22" ref-type="bibr">Linn et al., 2010</xref>), we stratified the participants into three groups: probable-CAA (patients fulfilling Boston criteria for probable CAA); cSVD subjects not fulfilling criteria for either possible or probable CAA and presenting one or more of the other following MRI markers of cSVD: non-lobar cerebral microbleeds [CMB], and/or lacunes, and/or high-grade (&gt;2) basal ganglia perivascular spaces (PVS) (<xref rid="B28" ref-type="bibr">Potter et al., 2015</xref>), and/or deep Fazekas score (<xref rid="B14" ref-type="bibr">Fazekas et al., 1987</xref>) ≥ 2 and/or periventricular Fazekas score [<xref rid="B14" ref-type="bibr">Fazekas et al. (1987)</xref> = 3]; and non-cSVD (subjects without any of the above neuroimaging markers of cSVD). None of the cSVD subjects had any MRI or clinical features suggesting a hereditary/monogenic pathology. Therefore, they are presumably affected by the most prevalent etiological subtype of sporadic cSVD, related to aging and/or vascular risk factors such as hypertension (arteriolosclerosis/deep perforator arteriopathy).</p></sec><sec id="S2.SS2"><title>Clinical and neuropsychological assessment</title><p>Demographic and clinical data were collected from each participant upon enrollment. All memory-clinic subjects underwent a thorough and standardized neuropsychological test battery. We explored four different cognitive domains through composite scores created by clustering and averaging performance on different neuropsychological tests (<xref rid="B56" ref-type="bibr">Weintraub et al., 2009</xref>): Executive function [Trail Making Test B (<xref rid="B8" ref-type="bibr">Corrigan and Hinkeldey, 1987</xref>) and Digit Span Backward (<xref rid="B19" ref-type="bibr">Joy et al., 2004</xref>)] processing speed/attention [Trail Making Test A (<xref rid="B34" ref-type="bibr">Sánchez-Cubillo et al., 2009</xref>), Digit Span Forward (<xref rid="B19" ref-type="bibr">Joy et al., 2004</xref>), and WAIS-III (Wechsler Adult Intelligence Scale-Third Edition) Digit Symbol Coding (<xref rid="B19" ref-type="bibr">Joy et al., 2004</xref>)], memory [Hopkins Verbal Learning Test-Revised (<xref rid="B6" ref-type="bibr">Brandt, 1991</xref>) and Wechsler Memory Scale logical memory (<xref rid="B54" ref-type="bibr">Wechsler, 1987</xref>); immediate recall and delayed recall], and language function [Boston Naming Test (<xref rid="B24" ref-type="bibr">Mack et al., 1992</xref>) and Animal Naming (<xref rid="B44" ref-type="bibr">Tombaugh et al., 1999</xref>)]. First, based on published normative data (<xref rid="B9" ref-type="bibr">Crum et al., 1993</xref>; <xref rid="B13" ref-type="bibr">Fastenau et al., 1998</xref>; <xref rid="B43" ref-type="bibr">Tombaugh, 2004</xref>), we transformed performance on each test into z-scores adjusted for gender, age, and education level. Then, these z-scores were averaged within composite domains to compute the domain-specific scores for each participant.</p></sec><sec id="S2.SS3"><title>MRI acquisition</title><p>All exams were performed on a 3-T MRI scanner (Siemens Healthcare, Magnetom Prisma-Fit, or TIM-Trio), using a 32-channel head coil. The scan protocol included: a 3D T1-weighted sequence (repetition time [TR] 2,300–2,510 ms; echo time [TE] 1.69–2.98 ms; resolution 1 × 1 × 1 mm), a 3D fluid-attenuated inversion recovery sequence (FLAIR, TR 5,000–6,000 ms; TE 356–455 ms; resolution 1 × 1 × 1 mm), a susceptibility-weighted imaging sequence (SWI, TR 27–30; TE 20; slice thickness, 1.4 mm; in-plane resolution 0.9 × 0.9 mm), and a 3D multi-directional diffusion-weighted imaging sequence (DWI, 60–64 directions; TR 8,000–8,040 ms; TE 82–84 ms; resolution 2 × 2 × 2 mm; b-value, 700 s/mm<sup>2</sup>).</p></sec><sec id="S2.SS4"><title>Peak width of skeletonized mean diffusivity processing</title><p>Initially, a careful visual inspection of all DWI images was conducted, and cases with excessive motion artifacts were excluded. To objectively and quantitatively evaluate the magnitude of head motion during the acquisition of DWI images, we further extracted registration- and intensity-based measures to compute the Total Motion Index (TMI) proposed by <xref rid="B58" ref-type="bibr">Yendiki et al. (2014)</xref>. TMI was originally developed to be used as a nuisance regressor to account for motion confounding in neuroimaging studies (<xref rid="B58" ref-type="bibr">Yendiki et al., 2014</xref>). Since the intensity-based measures did not show significant variability across our subjects, only the registration-based measures were applied in the TMI formula.</p><p>We ran the fully automated PSMD script (version 1.0/2016)<sup><xref rid="footnote1" ref-type="fn">1</xref></sup> (<xref rid="B4" ref-type="bibr">Baykara et al., 2016</xref>), including all the pre-processing steps, relying on the Functional Magnetic Resonance Imaging of the Brain (FMRIB) Software Library (FSL) version 6.0.1 (<xref rid="B18" ref-type="bibr">Jenkinson et al., 2012</xref>). Briefly, the script runs motion and eddy-currents correction (<xref rid="B1" ref-type="bibr">Andersson and Sotiropoulos, 2015</xref>), brain extraction (<xref rid="B40" ref-type="bibr">Smith, 2002</xref>), and tensor fitting as pre-processing steps, obtaining maps of MD and FA. These maps are fed into tract-based spatial statistics (TBSS), as implemented in FSL (<xref rid="B41" ref-type="bibr">Smith et al., 2006</xref>), to achieve skeletonization of the main WM tracts. The obtained skeletonized MD maps are further masked with a custom mask to exclude areas prone to CSF contamination. Finally, a histogram analysis is conducted on the final MD maps, and the difference between percentiles 5 and 95 is computed to obtain PSMD values for each individual. Similar procedures were used to compute skeletonized average MD (<xref rid="B25" ref-type="bibr">McCreary et al., 2020</xref>) and FA values.</p></sec><sec id="S2.SS5"><title>Regional distribution of peak width of skeletonized mean diffusivity</title><p>To investigate potential differences in the white matter microstructural integrity across the anteroposterior axis, we used MNI152 atlas to create masks of the frontal and occipital lobes, manually filling missing voxels in the deep and periventricular WM areas (<xref rid="F1" ref-type="fig">Figure 1A</xref>).</p><fig position="float" id="F1" orientation="portrait"><label>FIGURE 1</label><caption><p>Regional differences in PSMD values between probable-CAA, cSVD and non-cSVD groups. <bold>(A)</bold> Frontal (blue) and occipital (red) masks, used to compute lobe-specific PSMD values. <bold>(B)</bold> The line graph depicts mean log-PSMD values in the frontal and occipital lobes of probable-CAA (solid line), cSVD (dashed line), and non-cSVD (dotted line) subjects. <bold>(C–H)</bold> Box-plots of PSMD values. The boxes extend from the 25th to 75th percentiles, and the solid line within each box represents the median. The superior and inferior inner fences represent the 75th percentile plus 1.5 times the interquartile range and the 25th minus 1.5 times the interquartile range, respectively. Outliers are displayed by symbols. <bold>(C</bold>–<bold>E)</bold> Box plots contrasting frontal <bold>(C)</bold>, occipital <bold>(D)</bold>, and total <bold>(E)</bold> PSMD values between non-cSVD, cSVD, and probable-CAA groups. <bold>(F–H)</bold> Box-plots display frontal (blue) and occipital (red) PSMD within each study group. General linear models adjusted for age are indicated by the brackets, with <italic toggle="yes">p</italic>-values (*<italic toggle="yes">p</italic> &lt; 0.05; ** <italic toggle="yes">p</italic> &lt; 0.01; *** <italic toggle="yes">p</italic> &lt; 0.001).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fnins-16-1051038-g001.jpg"/></fig><p>We applied these two masks separately to all subjects and computed PSMD, skeletonized average MD, and skeletonized average FA values restricted to the frontal and occipital lobes. To depict variations across the anteroposterior axis, we computed occipital-frontal gradients (occipital—frontal DTI metrics) for each participant.</p></sec><sec id="S2.SS6"><title>Conventional neuroimaging markers</title><p>Conventional MRI markers of cSVD were rated by a neuroradiologist (M. C. Z. Z.), blinded to all clinical data, following the Standards for Reporting Vascular Changes on Neuroimaging (STRIVE) recommendations (<xref rid="B53" ref-type="bibr">Wardlaw et al., 2013</xref>). CMBs were evaluated on SWI for presence, number, and location (<xref rid="B53" ref-type="bibr">Wardlaw et al., 2013</xref>). Lacunes were evaluated on FLAIR images as lesions measuring 3–15 mm, isointense to CSF, with hyperintense margins (<xref rid="B53" ref-type="bibr">Wardlaw et al., 2013</xref>). We evaluated SWI for the presence of cortical superficial siderosis (cSS) (<xref rid="B22" ref-type="bibr">Linn et al., 2010</xref>). Cortical cerebral microinfarcts (CMIs), defined as lesions ≤4 mm, restricted to the cortex, hypointense on T1, and hyperintense on FLAIR, were counted across the whole brain (<xref rid="B48" ref-type="bibr">van Veluw et al., 2017</xref>). We rated PVS in the centrum semiovale (CSO-PVS) and the basal ganglia (BG-PVS), using T1-weighted images, according to a previously proposed scale: 0 (none); 1 (1–10); 2 (11–20); 3 (21–40); 4 (&gt;40) (<xref rid="B28" ref-type="bibr">Potter et al., 2015</xref>). White matter hyperintensities (WMH) were qualitatively assessed using a validated visual scale (<xref rid="B14" ref-type="bibr">Fazekas et al., 1987</xref>).</p><p>We used the <italic toggle="yes">FreeSurfer</italic> software suite (version 6.0)<sup><xref rid="footnote2" ref-type="fn">2</xref></sup> (<xref rid="B10" ref-type="bibr">Dale et al., 1999</xref>) to compute total brain volume (TBV) and total intracranial volume (ICV), following a rigorous visual quality inspection. The normalized TBV (nTBV) was calculated as the TBV/ICV ratio multiplied by 100, and was expressed in units of percent ICV. We used the lesion prediction algorithm (<xref rid="B35" ref-type="bibr">Schmidt, 2017</xref>) implemented in the toolbox Lesion Segmentation Tool version 3.0.0<sup><xref rid="footnote3" ref-type="fn">3</xref></sup> for Statistical Parametric Mapping 12 to segment WM hyperintense lesions, following visual inspection for segmentation quality. Different lesion probability thresholds were evaluated on 40 randomly selected individuals from our cohort, and the ideal threshold of 0.5 was defined by careful visual inspection against their respective FLAIR images for accuracy. We calculated normalized WMH volume (nWMHV) as the WMHV/ICV ratio multiplied by 100 and expressed in units of percent ICV.</p></sec><sec id="S2.SS7"><title>Statistical analysis</title><p>The distribution of continuous variables was tested for normality using the Shapiro-Wilk test. Clinical, neuropsychological, and neuroimaging characteristics were compared across the three groups using χ2 or Fisher test and Kruskal-Wallis H test or ANOVA, as appropriate.</p><p>We investigated the association between TMI and DTI metrics across all subjects, using simple linear regression, further adjusting for age, gender, and education level to evaluate motion effects. Neuroimaging and cognitive associations were investigated only in the probable CAA group. These analyses were restricted to the probable CAA group because we intended to investigate PSMD’s performance specifically in the context of the second most common form of sporadic cSVD, for which there is still limited data available in the literature. Linear regression models exploring the associations between DTI metrics and conventional neuroimaging markers were adjusted for age, and those investigating cognitive associations were adjusted for the time interval between the MRI and the neuropsychological tests. Since cognitive scores had already been adjusted for age, gender, and education level, we did not include these variables in the models. We further assessed the relative contribution of each neuroimaging variable by running multiple linear regression models and applying a decomposition method proposed by <xref rid="B21" ref-type="bibr">Lindeman et al. (1980)</xref> and available in the Relaimpo R package (v2.2) (<xref rid="B16" ref-type="bibr">Grömping, 2006</xref>).</p><p>Non-parametric variables were log-transformed for the regional analyses. To investigate regional variances in PSMD, MD, and FA we compared occipital-frontal gradients between the groups, using ANCOVA, adjusting for age. Furthermore, to evaluate whether CAA diagnosis could influence regional variances in DTI metrics, we compared probable-CAA subjects against non-cSVD and cSVD subjects. We used mixed-factor ANOVA to investigate whether there was an interaction between group and region on PSMD, MD, and FA values. We further investigated the simple main effects of group and region using ANCOVA adjusted for age and repeated-measures ANOVA, respectively. All pairwise comparisons were adjusted for false discovery rate (FDR) using the Benjamini-Hochberg procedure.</p><p>The statistical significance level was set at 0.05 for all analyses. We used the Statistical Package for the Social Sciences (SPSS) version 20.0 (for IOS; SPSS Inc., Chicago, IL), Prism (v8.4.3), and R (v3.5.3) to run the analyses.</p></sec></sec><sec sec-type="results" id="S3"><title>Results</title><p>We screened 167 subjects from our memory-clinic cohort who underwent complete research MRI and neuropsychological exam. Of those subjects, 77 were excluded, based on the following pre-specified criteria: dementia (<italic toggle="yes">n</italic> = 46), excessive motion artifacts on visual inspection (<italic toggle="yes">n</italic> = 3); possible-CAA (<italic toggle="yes">n</italic> = 26); and mixed pattern of distribution of hemorrhagic features (<italic toggle="yes">n</italic> = 2). The final cohort was comprised of 90 non-demented memory-clinic subjects (43 probable-CAA, 17 non-CAA-cSVD and 30 non-cSVD). The median delay between MRI and neuropsychological tests was 0 [IQR, 0–2.5] months.</p><p>In simple linear regression analysis, TMI was not association with any DTI metric (Standardized β coefficient [95% confidence interval]; PSMD β [95% CI] = −0.027 [−0.239, 0.185], <italic toggle="yes">p</italic> = 0.802; MD β [95% CI] = −0.038 [−0.250, 0.173], <italic toggle="yes">p</italic> = 0.721; FA β [95% CI] = 0.051 [−0.160, 0.263], <italic toggle="yes">p</italic> = 0.632), even after adjusting for age, gender and education level. Therefore, we did not include TMI as a covariate in the neuroimaging and cognitive analyses.</p><sec id="S3.SS1"><title>Between-group comparisons</title><p>Demographic, neuropsychological, and neuroimaging data from each group are summarized in <xref rid="T1" ref-type="table">Table 1</xref>. Groups differed in age [<italic toggle="yes">F</italic>(2, 87) = 9.326, <italic toggle="yes">p</italic> &lt; 0.001], with both probable-CAA (mean difference ± standard error, 4.67 ± 1.52; FDR-adjusted <italic toggle="yes">p</italic>-value = 0.004) and cSVD (7.95 ± 1.94; <italic toggle="yes">p</italic> &lt; 0.001) being older than non-cSVD subjects. Gender, education level, vascular risk factors, cognitive performance, and head motion (TMI) were evenly distributed across the groups. As expected, the burden of cSVD markers was higher in the probable-CAA and cSVD groups compared to the non-cSVD group. nTBV differed across the groups [<italic toggle="yes">F</italic>(2, 87) = 8.905, <italic toggle="yes">p</italic> &lt; 0.001], with greater atrophy in probable CAA subjects than in non-cSVD participants (−3.94 ± 0.93; <italic toggle="yes">p</italic> &lt; 0.001). PSMD values also differed across the groups, and were lower in the non-cSVD group in comparison to probable-CAA (<italic toggle="yes">p</italic> &lt; 0.001) and cSVD (<italic toggle="yes">p</italic> &lt; 0.001). PSMD did not differ between probable-CAA and cSVD groups (<italic toggle="yes">p</italic> = 0.883). On the other hand, MD values were higher in probable-CAA patients, and FA values were lower in CAA patients, compared to both cSVD and non-cSVD groups (<italic toggle="yes">p</italic> &lt; 0.001).</p><table-wrap position="float" id="T1" orientation="portrait"><label>TABLE 1</label><caption><p>Summary of clinical and neuroimaging data.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">Total<break/> (<italic toggle="yes">n</italic> = 90)</td><td valign="top" align="center" colspan="2" rowspan="1">Non-CAA</td><td valign="top" align="center" rowspan="1" colspan="1">Probable-CAA<xref rid="t1fna" ref-type="table-fn"><sup>c</sup></xref> (<italic toggle="yes">n</italic> = 43)</td><td valign="top" align="center" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" colspan="2" rowspan="1">
<hr/>
</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">non-cSVD<xref rid="t1fna" ref-type="table-fn"><sup>a</sup></xref><break/> (<italic toggle="yes">n</italic> = 30)</td><td valign="top" align="center" rowspan="1" colspan="1">cSVD<xref rid="t1fna" ref-type="table-fn"><sup>b</sup></xref><break/> (<italic toggle="yes">n</italic> = 17)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="left" colspan="6" rowspan="1">
<bold>Demographics</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (years), mean (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">73.5 (7.0)</td><td valign="top" align="center" rowspan="1" colspan="1">69.7 (7.4)</td><td valign="top" align="center" rowspan="1" colspan="1">77.7 (5.4)</td><td valign="top" align="center" rowspan="1" colspan="1">74.4 (5.9)</td><td valign="top" align="center" rowspan="1" colspan="1">b &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref><break/> c &gt; a<xref rid="t1fns2" ref-type="table-fn">**</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Female, n (%)</td><td valign="top" align="center" rowspan="1" colspan="1">45 (50)</td><td valign="top" align="center" rowspan="1" colspan="1">16 (53.3)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (47.1)</td><td valign="top" align="center" rowspan="1" colspan="1">21 (48.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.898</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Education (years), median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">16 [14–18]</td><td valign="top" align="center" rowspan="1" colspan="1">16 [14–18]</td><td valign="top" align="center" rowspan="1" colspan="1">16 [14–17]</td><td valign="top" align="center" rowspan="1" colspan="1">17 [16–19]</td><td valign="top" align="center" rowspan="1" colspan="1">0.064</td></tr><tr><td valign="top" align="left" colspan="6" rowspan="1">
<bold>Vascular risk factors</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hypertension, n (%)<xref rid="t1fnd1" ref-type="table-fn"><sup>†</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">55 (65.5)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (72.0)</td><td valign="top" align="center" rowspan="1" colspan="1">11 (68.8)</td><td valign="top" align="center" rowspan="1" colspan="1">26 (60.5)</td><td valign="top" align="center" rowspan="1" colspan="1">0.599</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Diabetes, n (%)<xref rid="t1fnd1" ref-type="table-fn"><sup>†</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">11 (13.1)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (8.0)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (31.2)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (9.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.071</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Atrial fibrillation, n (%)<xref rid="t1fnd1" ref-type="table-fn"><sup>†</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.8)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (4.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (6.2)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (4.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Dyslipidemia, n (%)<xref rid="t1fnd1" ref-type="table-fn"><sup>†</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">68 (81.0)</td><td valign="top" align="center" rowspan="1" colspan="1">19 (76.0)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (81.2)</td><td valign="top" align="center" rowspan="1" colspan="1">36 (83.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.761</td></tr><tr><td valign="top" align="left" colspan="6" rowspan="1">
<bold>Cognitive scores (z-scores)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MMSE, mean (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">−0.11 (1.43)</td><td valign="top" align="center" rowspan="1" colspan="1">−0.18 (1.53)</td><td valign="top" align="center" rowspan="1" colspan="1">0.51 (1.29)</td><td valign="top" align="center" rowspan="1" colspan="1">−0.30 (1.38)</td><td valign="top" align="center" rowspan="1" colspan="1">0.132</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Memory, mean (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">−0.38 (1.25)</td><td valign="top" align="center" rowspan="1" colspan="1">−0.14 (1.29)</td><td valign="top" align="center" rowspan="1" colspan="1">−0.04 (1.19)</td><td valign="top" align="center" rowspan="1" colspan="1">−0.67 (1.2)</td><td valign="top" align="center" rowspan="1" colspan="1">0.092</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Processing speed, mean (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">−0.07 (0.53)</td><td valign="top" align="center" rowspan="1" colspan="1">−0.04 (0.50)</td><td valign="top" align="center" rowspan="1" colspan="1">−0.08 (0.54)</td><td valign="top" align="center" rowspan="1" colspan="1">−0.09 (0.55)</td><td valign="top" align="center" rowspan="1" colspan="1">0.921</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Language, mean (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">−0.34 (1.02)</td><td valign="top" align="center" rowspan="1" colspan="1">−0.21 (0.81)</td><td valign="top" align="center" rowspan="1" colspan="1">−0.27 (1.35)</td><td valign="top" align="center" rowspan="1" colspan="1">−0.46 (1.02)</td><td valign="top" align="center" rowspan="1" colspan="1">0.570</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Executive function, median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">−0.26 [−0.8, 0.1]</td><td valign="top" align="center" rowspan="1" colspan="1">−0.23 [−0.6, 0.2]</td><td valign="top" align="center" rowspan="1" colspan="1">−0.07 [−0.6, 0.1]</td><td valign="top" align="center" rowspan="1" colspan="1">−0.37 [−1.0, 0.1]</td><td valign="top" align="center" rowspan="1" colspan="1">0.413</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Gap MRIxNPT, months, median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">0 [−2.3, 0]</td><td valign="top" align="center" rowspan="1" colspan="1">−1.05 [−3.4, 0]</td><td valign="top" align="center" rowspan="1" colspan="1">−1.33 [−2.8, 0.2]</td><td valign="top" align="center" rowspan="1" colspan="1">0 [−1.6, 0]</td><td valign="top" align="center" rowspan="1" colspan="1">0.034<xref rid="t1fnd2" ref-type="table-fn"><sup>‡</sup></xref></td></tr><tr><td valign="top" align="left" colspan="6" rowspan="1">
<bold>Conventional MRI markers</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lobar CMB count, median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">0 [0, 13.5]</td><td valign="top" align="center" rowspan="1" colspan="1">0 [0, 0]</td><td valign="top" align="center" rowspan="1" colspan="1">0 [0, 0]</td><td valign="top" align="center" rowspan="1" colspan="1">15 [3, 55]</td><td valign="top" align="center" rowspan="1" colspan="1">c &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref><break/> c &gt; b<xref rid="t1fns3" ref-type="table-fn">***</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">cSS (presence), n (%)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (15.6)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (32.6)</td><td valign="top" align="center" rowspan="1" colspan="1">c &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref><break/> c &gt; b<xref rid="t1fns3" ref-type="table-fn">***</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lacunes count, median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">0 [0, 1]</td><td valign="top" align="center" rowspan="1" colspan="1">0 [0, 0]</td><td valign="top" align="center" rowspan="1" colspan="1">1 [0, 1.5]</td><td valign="top" align="center" rowspan="1" colspan="1">0 [0, 1]</td><td valign="top" align="center" rowspan="1" colspan="1">b &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref><break/> c &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cortical CMI, count, median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">0 [0, 0]</td><td valign="top" align="center" rowspan="1" colspan="1">0 [0, 0]</td><td valign="top" align="center" rowspan="1" colspan="1">0 [0, 0]</td><td valign="top" align="center" rowspan="1" colspan="1">0 [0, 1]</td><td valign="top" align="center" rowspan="1" colspan="1">0.049<xref rid="t1fnd2" ref-type="table-fn"><sup>‡</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CSO PVS score, median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">2 [2, 3]</td><td valign="top" align="center" rowspan="1" colspan="1">2 [1, 2]</td><td valign="top" align="center" rowspan="1" colspan="1">2 [2, 2]</td><td valign="top" align="center" rowspan="1" colspan="1">3 [2, 4]</td><td valign="top" align="center" rowspan="1" colspan="1">c &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref><break/> c &gt; b<xref rid="t1fns2" ref-type="table-fn">**</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BG PVS score, median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">2 [1, 2]</td><td valign="top" align="center" rowspan="1" colspan="1">1 [1, 2]</td><td valign="top" align="center" rowspan="1" colspan="1">2 [2, 3]</td><td valign="top" align="center" rowspan="1" colspan="1">2 [1, 3]</td><td valign="top" align="center" rowspan="1" colspan="1">b &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref><break/> c &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">nWMHV (% ICV), median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">0.2 [0.05, 0.8]</td><td valign="top" align="center" rowspan="1" colspan="1">0.05 [0.01, 0.1]</td><td valign="top" align="center" rowspan="1" colspan="1">0.66 [0.3, 1.2]</td><td valign="top" align="center" rowspan="1" colspan="1">0.36 [0.14, 1.8]</td><td valign="top" align="center" rowspan="1" colspan="1">b &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref><break/> c &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">nTBV (% ICV), mean (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">64.75 (4.26)</td><td valign="top" align="center" rowspan="1" colspan="1">67.06 (4.46)</td><td valign="top" align="center" rowspan="1" colspan="1">64.77 (3.26)</td><td valign="top" align="center" rowspan="1" colspan="1">63.13 (3.76)</td><td valign="top" align="center" rowspan="1" colspan="1">a &gt; c<xref rid="t1fns3" ref-type="table-fn">***</xref></td></tr><tr><td valign="top" align="left" colspan="6" rowspan="1">
<bold>DTI global markers</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PSMD (×10<sup>–4</sup> mm<sup>2</sup>/s), median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">3.76 [3.32, 4.37]</td><td valign="top" align="center" rowspan="1" colspan="1">3.30 [3.13, 3.60]</td><td valign="top" align="center" rowspan="1" colspan="1">4.07 [3.51, 4.62]</td><td valign="top" align="center" rowspan="1" colspan="1">4.06 [3.58, 4.79]</td><td valign="top" align="center" rowspan="1" colspan="1">b &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref><break/> c &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Average MD (×10<sup>–4</sup> mm<sup>2</sup>/s), median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">8.44[7.86, 9.2]</td><td valign="top" align="center" rowspan="1" colspan="1">7.98 [7.49, 8.61]</td><td valign="top" align="center" rowspan="1" colspan="1">8.06 [7.75, 8.30]</td><td valign="top" align="center" rowspan="1" colspan="1">9.19 [8.45, 9.83]</td><td valign="top" align="center" rowspan="1" colspan="1">c &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref><break/> c &gt; b<xref rid="t1fns3" ref-type="table-fn">***</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Average FA, mean (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">0.46 (0.04)</td><td valign="top" align="center" rowspan="1" colspan="1">0.49 (0.04)</td><td valign="top" align="center" rowspan="1" colspan="1">0.48 (0.03)</td><td valign="top" align="center" rowspan="1" colspan="1">0.44 (0.04)</td><td valign="top" align="center" rowspan="1" colspan="1">a &gt; c<xref rid="t1fns3" ref-type="table-fn">***</xref><break/> b &gt; c<xref rid="t1fns3" ref-type="table-fn">***</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total motion index, median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">−0.07 [−0.96, 1.26]</td><td valign="top" align="center" rowspan="1" colspan="1">0.24[−1.07, 1.3]</td><td valign="top" align="center" rowspan="1" colspan="1">0.21 [−0.66, 1.9]</td><td valign="top" align="center" rowspan="1" colspan="1">−0.25 [−0.94, 0.6]</td><td valign="top" align="center" rowspan="1" colspan="1">0.426</td></tr><tr><td valign="top" align="left" colspan="6" rowspan="1">
<bold>DTI regional assessment</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Frontal PSMD (×10<sup>–4</sup> mm<sup>2</sup>/s), median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">3.14 [2.77, 3.50]</td><td valign="top" align="center" rowspan="1" colspan="1">2.81 [2.52, 3.17]</td><td valign="top" align="center" rowspan="1" colspan="1">3.26 [3.00, 3.89]</td><td valign="top" align="center" rowspan="1" colspan="1">3.20 [3.03, 3.94]</td><td valign="top" align="center" rowspan="1" colspan="1">b &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref><break/> c &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Occipital PSMD (×10<sup>–4</sup> mm<sup>2</sup>/s), median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">3.77 [3.23, 4.50]</td><td valign="top" align="center" rowspan="1" colspan="1">3.23 [2.82, 3.70]</td><td valign="top" align="center" rowspan="1" colspan="1">3.76 [3.53, 4.06]</td><td valign="top" align="center" rowspan="1" colspan="1">4.44 [3.68, 5.00]</td><td valign="top" align="center" rowspan="1" colspan="1">b &gt; a<xref rid="t1fns1" ref-type="table-fn">*</xref><break/> c &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Occipital-frontal PSMD gradient (×10<sup>–4</sup> mm<sup>2</sup>/s), mean (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">0.76 (1.08)</td><td valign="top" align="center" rowspan="1" colspan="1">0.43 (0.54)</td><td valign="top" align="center" rowspan="1" colspan="1">0.45 (1.19)</td><td valign="top" align="center" rowspan="1" colspan="1">1.11 (1.22)</td><td valign="top" align="center" rowspan="1" colspan="1">c &gt; a<xref rid="t1fns1" ref-type="table-fn">*</xref><break/> c &gt; b<xref rid="t1fns1" ref-type="table-fn">*</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Frontal average MD (×10<sup>–4</sup> mm<sup>2</sup>/s), median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">8.17 [7.74, 9.00]</td><td valign="top" align="center" rowspan="1" colspan="1">7.84 [7.25, 8.38]</td><td valign="top" align="center" rowspan="1" colspan="1">7.90 [7.60, 8.14]</td><td valign="top" align="center" rowspan="1" colspan="1">8.98 [8.15, 9.55]</td><td valign="top" align="center" rowspan="1" colspan="1">c &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref><break/> c &gt; b<xref rid="t1fns3" ref-type="table-fn">***</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Occipital average MD (×10<sup>–4</sup> mm<sup>2</sup>/s), median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">8.53 [8.14, 9.53]</td><td valign="top" align="center" rowspan="1" colspan="1">8.27 [7.80, 8.51]</td><td valign="top" align="center" rowspan="1" colspan="1">8.13 [7.78, 8.49]</td><td valign="top" align="center" rowspan="1" colspan="1">9.35 [8.67, 9.81]</td><td valign="top" align="center" rowspan="1" colspan="1">c &gt; a<xref rid="t1fns3" ref-type="table-fn">***</xref><break/> c &gt; b<xref rid="t1fns3" ref-type="table-fn">***</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Occipital-frontal Average MD gradient (×10<sup>–4</sup> mm<sup>2</sup>/s), mean (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">0.39 (0.45)</td><td valign="top" align="center" rowspan="1" colspan="1">0.46 (0.27)</td><td valign="top" align="center" rowspan="1" colspan="1">0.23 (0.40)</td><td valign="top" align="center" rowspan="1" colspan="1">0.41 (0.55)</td><td valign="top" align="center" rowspan="1" colspan="1">0.250</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Frontal average FA, mean (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">0.42 (0.04)</td><td valign="top" align="center" rowspan="1" colspan="1">0.45 (0.04)</td><td valign="top" align="center" rowspan="1" colspan="1">0.43 (0.03)</td><td valign="top" align="center" rowspan="1" colspan="1">0.40 (0.04)</td><td valign="top" align="center" rowspan="1" colspan="1">a &gt; c<xref rid="t1fns3" ref-type="table-fn">***</xref><break/> b &gt; c<xref rid="t1fns3" ref-type="table-fn">***</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Occipital average FA, mean (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">0.44 (0.05)</td><td valign="top" align="center" rowspan="1" colspan="1">0.47 (0.04)</td><td valign="top" align="center" rowspan="1" colspan="1">0.45 (0.03)</td><td valign="top" align="center" rowspan="1" colspan="1">0.41 (0.04)</td><td valign="top" align="center" rowspan="1" colspan="1">a &gt; c<xref rid="t1fns3" ref-type="table-fn">***</xref><break/> b &gt; c<xref rid="t1fns3" ref-type="table-fn">***</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Occipital-frontal average FA gradient, median [IQR]</td><td valign="top" align="center" rowspan="1" colspan="1">0.02 [0.01, 0.03]</td><td valign="top" align="center" rowspan="1" colspan="1">0.03 [0.02, 0.03]</td><td valign="top" align="center" rowspan="1" colspan="1">0.03 [0.00, 0.04]</td><td valign="top" align="center" rowspan="1" colspan="1">0.02 [0.01, 0.03]</td><td valign="top" align="center" rowspan="1" colspan="1">0.130</td></tr></tbody></table><table-wrap-foot><fn><p>Kruskal Wallis and ANOVA were used to investigate differences across the three groups, as appropriate.</p></fn><fn id="t1fnd1"><p><sup>†</sup>Six missing values.</p></fn><fn id="t1fns1"><p>We reported the original <italic toggle="yes">p</italic>-values and, when significant differences were found, we ran FDR-adjusted pairwise comparisons: *FDR-adjusted <italic toggle="yes">p</italic> &lt; 0.05.</p></fn><fn id="t1fns2"><p>**FDR-adjusted <italic toggle="yes">p</italic> &lt; 0.01.</p></fn><fn id="t1fns3"><p>***FDR-adjusted <italic toggle="yes">p</italic> &lt; 0.001.</p></fn><fn id="t1fnd2"><p><sup>‡</sup>No statistical significance in pairwise comparisons, after FDR-correction.</p></fn><fn><p>SD, standard deviation; IQR, interquartile range; MMSE, mini mental state examination; CMB, cerebral microbleeds; cSS, cortical superficial siderosis; CMI, cerebral microinfarcts; CSO-PVS, perivascular spaces in the centrum semiovale; BG-PVS, perivascular spaces in the basal ganglia; nWMHV, normalized white matter hyperintensity volume; nTBV, normalized total brain volume; CAA, cerebral amyloid angiopathy; cSVD, cerebral small vessel disease; PSMD, peak width of skeletonized mean diffusivity. Probable-CAA, patients fulfilling the modified Boston criteria for Probable CAA; cSVD, patients with neuroimaging markers of cSVD not attributable to CAA—presumed arteriolosclerosis; non-cSVD, patients without neuroimaging markers of cSVD.</p></fn><fn id="t1fna"><p><sup>a</sup>Non-cSVD group; <sup>b</sup>cSVD group; <sup>C</sup>Probable CAA group.</p></fn></table-wrap-foot></table-wrap></sec><sec id="S3.SS2"><title>Regional diffusion tensor imaging analyses</title><p>Controlling for age, occipital-frontal PSMD gradients were different across the three groups [<italic toggle="yes">F</italic>(2, 86) = 4.278, <italic toggle="yes">p</italic> = 0.017, partial η<sup>2</sup> = 0.090]. Probable-CAA subjects presented higher occipital-frontal PSMD gradients in comparison to both cSVD (0.734 ± 0.30 × 10<sup>–4</sup> mm<sup>2</sup>/s, <italic toggle="yes">p</italic> = 0.046) and non-cSVD (0.567 ± 0.26 × 10<sup>–4</sup> mm<sup>2</sup>/s, <italic toggle="yes">p</italic> = 0.046) groups. There was a significant interaction between region (frontal x occipital) and group (non-cSVD, cSVD, probable-CAA) on PSMD values [<italic toggle="yes">F</italic>(2, 87) = 3.887, <italic toggle="yes">p</italic> = 0.024, partial η<sup>2</sup> = 0.082, <xref rid="F1" ref-type="fig">Figure 1B</xref>]. Frontal PSMD values, adjusted for age, were lower in the non-cSVD group in comparison to cSVD (mean difference ± standard error; FDR-adjusted <italic toggle="yes">p</italic>-values; −0.071 ± 0.03 × 10<sup>–4</sup> mm<sup>2</sup>/s, <italic toggle="yes">p</italic> = 0.017) and probable-CAA (−0.070 ± 0.02 × 10<sup>–4</sup> mm<sup>2</sup>/s, <italic toggle="yes">p</italic> = 0.004) groups, but were similar in the latter two (−0.001 ± 0.02 × 10<sup>–4</sup> mm<sup>2</sup>/s, <italic toggle="yes">p</italic> = 0.955; <xref rid="F1" ref-type="fig">Figure 1C</xref>). PSMD values from the occipital lobes, adjusted for age, were higher in probable-CAA in comparison to cSVD (0.069 ± 0.03 × 10<sup>–4</sup> mm<sup>2</sup>/s, <italic toggle="yes">p</italic> = 0.026) and non-cSVD (0.117 ± 0.02 × 10<sup>–4</sup> mm<sup>2</sup>/s, <italic toggle="yes">p</italic> &lt; 0.001; <xref rid="F1" ref-type="fig">Figure 1D</xref>) groups. Occipital PSMD values were higher than frontal values in probable-CAA [<italic toggle="yes">F</italic>(1, 42) = 46.059, <italic toggle="yes">p</italic> &lt; 0.001, η<sup>2</sup> = 0.523] and non-cSVD [<italic toggle="yes">F</italic>(1, 29) = 18.755, <italic toggle="yes">p</italic> &lt; 0.001, partial η<sup>2</sup> = 0.393] groups, but not in the cSVD group [<italic toggle="yes">F</italic>(1, 16) = 3.342, <italic toggle="yes">p</italic> = 0.086, partial η<sup>2</sup> = 0.173; <xref rid="F1" ref-type="fig">Figures 1F–H</xref>].</p><p>A similar analysis performed with MD data revealed: (1) controlling for age, occipital-frontal MD gradients did not differ across the three groups [<italic toggle="yes">F</italic>(2, 86) = 1.446, <italic toggle="yes">p</italic> = 0.241, partial η<sup>2</sup> = 0.033]; (2) there was no significant interaction between region (frontal x occipital) and group (non-cSVD, cSVD, probable-CAA) on MD values [<italic toggle="yes">F</italic>(2, 87) = 1.782, <italic toggle="yes">p</italic> = 0.174, partial η<sup>2</sup> = 0.039]; (3) the main effect of region showed a statistically significant difference in MD values at different lobes [<italic toggle="yes">F</italic>(1, 87) = 59.915, <italic toggle="yes">p</italic> &lt; 0.001, partial η<sup>2</sup> = 0.408], with higher values in the occipital lobe (0.019 ± 0.002 × 10<sup>–4</sup> mm<sup>2</sup>/s, <italic toggle="yes">p</italic> &lt; 0.001); (4) the main effect of group showed that there was a statistically significant difference in MD values between the three groups [<italic toggle="yes">F</italic>(2, 87) = 25.004, <italic toggle="yes">p</italic> &lt; 0.001, partial η<sup>2</sup> = 0.365], with higher values observed in the probable CAA groups compared to both cSVD (0.052 ± 0.01 × 10<sup>–4</sup> mm<sup>2</sup>/s, <italic toggle="yes">p</italic> &lt; 0.001), and non-cSVD samples (0.051 ± 0.01 × 10<sup>–4</sup> mm<sup>2</sup>/s, <italic toggle="yes">p</italic> &lt; 0.001).</p><p>With regards to FA data, we observed: (1) controlling for age, occipital-frontal FA gradients were similar across the three groups [<italic toggle="yes">F</italic>(2, 86) = 0.769, <italic toggle="yes">p</italic> = 0.467, partial η<sup>2</sup> = 0.018]; (2) there was no significant interaction between region (frontal × occipital) and group (non-cSVD, cSVD, probable-CAA) on MD values [<italic toggle="yes">F</italic>(2, 87) = 0.574, <italic toggle="yes">p</italic> = 0.565, partial η<sup>2</sup> = 0.013]; (3) the main effect of region showed a statistically significant difference in FA values at different lobes [<italic toggle="yes">F</italic>(1, 87) = 93.253, <italic toggle="yes">p</italic> &lt; 0.001, partial η<sup>2</sup> = 0.517], with higher values in the occipital lobe (0.02 ± 0.002, <italic toggle="yes">p</italic> &lt; 0.001); (4) the main effect of group showed that there was a statistically significant difference in FA values between the three groups [<italic toggle="yes">F</italic>(2, 87) = 21.297, <italic toggle="yes">p</italic> &lt; 0.001, partial η<sup>2</sup> = 0.329], with lower values observed in the probable CAA groups compared to both cSVD (−0.041 ± 0.01, <italic toggle="yes">p</italic> &lt; 0.001), and non-cSVD samples (−0.056 ± 0.01, <italic toggle="yes">p</italic> &lt; 0.001).</p></sec><sec id="S3.SS3"><title>Relationship between diffusion tensor imaging markers and conventional MRI markers of cerebral small vessel diseases in cerebral amyloid angiopathy</title><p>Among probable-CAA subjects (<italic toggle="yes">n</italic> = 43), regression models with PSMD as the dependent variable, adjusting for age and correcting for multiple comparisons, revealed that higher PSMD was associated with higher number of lacunes (Standardized beta coefficient [95% confidence interval]; FDR-adjusted <italic toggle="yes">p</italic>-value; β [95% CI] = 0.38[0.09, 0.67]; <italic toggle="yes">p</italic> = 0.022), nWMHV (β [95% CI] = 0.86[0.69, 1.03]; <italic toggle="yes">p</italic> &lt; 0.001), and cortical CMI (β [95% CI] = 0.40[0.11, 0.69]; <italic toggle="yes">p</italic> = 0.022); and with lower nTBV (β [95% CI] = −0.48[−0.82, −0.14]; <italic toggle="yes">p</italic> = 0.022) (<xref rid="TS1" ref-type="supplementary-material">Supplementary Table 1</xref>). Among all MRI markers, nWMHV alone explained more than 65% of PSMD’s variance in the model (<xref rid="F2" ref-type="fig">Figure 2A</xref>). Similar analyses with average skeletonized MD and FA values revealed associations with BG PVS, CSO PVS, lobar cerebral microbleeds, and nWMHV (<xref rid="F2" ref-type="fig">Figures 2B,C</xref> and <xref rid="TS1" ref-type="supplementary-material">Supplementary Table 1</xref>).</p><fig position="float" id="F2" orientation="portrait"><label>FIGURE 2</label><caption><p>Associations between DTI metrics and conventional neuroimaging markers of cSVD in probable-CAA subjects. Bar graphs represent the relative contribution of each neuroimaging marker to explaining the variance in PSMD <bold>(A)</bold>, average skeletonized MD <bold>(B)</bold>, and average skeletonized FA <bold>(C)</bold> values among probable-CAA subjects. All neuroimaging markers were entered as independent variables in multiple linear regression models, with each DTI metric as the dependent variable. We applied a model decomposition method available in R package “Relaimpo” to compute the LMG metric. Metrics are normalized to sum to 100%. Lines represent 95% confidence intervals after 1,000 bootstrapping replications.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fnins-16-1051038-g002.jpg"/></fig></sec><sec id="S3.SS4"><title>Relationship between diffusion tensor imaging markers and cognitive functions in cerebral amyloid angiopathy</title><p>In the probable-CAA group, linear regression models corrected for time interval between MRI and NPT revealed that higher PSMD values are associated with worse performance in executive function (Standardized beta; FDR-adjusted <italic toggle="yes">p</italic>-value; β [95% CI] = −0.58[−0.87, −0.30]; <italic toggle="yes">p</italic> = 0.002) and processing speed (β [95% CI] = −0.46[−0.76, −0.17]; <italic toggle="yes">p</italic> = 0.03) (<xref rid="TS2" ref-type="supplementary-material">Supplementary Table 2</xref>). PSMD was not associated with other cognitive domains (<xref rid="TS2" ref-type="supplementary-material">Supplementary Table 2</xref>). Among all neuroimaging features, other than PSMD, only nWMHV showed an association with cognition, after correction for multiple comparisons (executive function; β [95% CI] = −0.54[−0.84, −0.24; <italic toggle="yes">p</italic> = 0.004]). MD and FA were not associated with performance in any of the cognitive domains investigated (<xref rid="TS2" ref-type="supplementary-material">Supplementary Table 2</xref>). In multiple regression models applying a model decomposition method, PSMD contributed more than the other conventional MRI markers in explaining cognitive variance in the domains of executive function and processing speed (<xref rid="F3" ref-type="fig">Figure 3</xref>).</p><fig position="float" id="F3" orientation="portrait"><label>FIGURE 3</label><caption><p>Associations between PSMD and performance in executive function and processing speed. Upper panel: Results from simple linear regression models between PSMD values and executive function <bold>(A. Above)</bold> and processing speed <bold>(B. Above)</bold> in probable-CAA subjects. 95% confidence intervals are depicted in gray. The provided R<sup>2</sup> and <italic toggle="yes">p</italic>-values reflect the obtained independent predictive of PSMD with regards to cognitive scores adjusted for the interval between MRI and neuropsychological tests. Lower panel: Bar graphs representing the relative contribution of each neuroimaging marker to explaining the variance in executive <bold>(A. Below)</bold> and processing speed scores <bold>(B. Below)</bold>, using the LMG metric computed with the R package “Relaimpo”. Metrics are normalized to sum to 100%. Lines represent 95% confidence intervals after 1,000 bootstrapping replications.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fnins-16-1051038-g003.jpg"/></fig><p>As an exploratory analysis, suggested during the revision process, we investigated the cognitive associations of lobe-specific DTI metrics and their occipital-frontal gradients. After correcting for multiple comparisons, only global and frontal PSMD values were significantly associated with cognitive performance (i.e., executive function) (<xref rid="TS3" ref-type="supplementary-material">Supplementary Table 3</xref>).</p></sec></sec><sec sec-type="discussion" id="S4"><title>Discussion</title><p>In this study in a well-characterized memory-clinic cohort, we aimed to further investigate PSMD’s role as neuroimaging marker in the context of CAA. First, we observed that PSMD was higher in individuals with cSVD than in those without evidence of cSVD but similar between different cSVD phenotypes (probable CAA and arteriolosclerosis). Second, taking a regional approach, we observed higher occipital-frontal PSMD gradients in probable-CAA than non-cSVD and cSVD subjects and found a significant interaction between diagnosis and regional PSMD variation. Third, in probable-CAA, PSMD differed from classical DTI metrics in terms of neuroimaging and cognitive associations. nWMHV was the main predictor of PSMD values, whereas MD and FA were more strongly associated with other markers, particularly with perivascular spaces. PSMD was associated with executive function and processing speed in subjects with probable CAA and explained more variance than conventional neuroimaging markers. MD and FA were not associated with cognitive performance.</p><p>Higher PSMD values observed in probable-CAA and cSVD subjects support the idea that PSMD, like other DTI measures, is particularly sensitive to cSVD-related abnormalities (<xref rid="B4" ref-type="bibr">Baykara et al., 2016</xref>; <xref rid="B15" ref-type="bibr">Finsterwalder et al., 2020</xref>; <xref rid="B23" ref-type="bibr">Low et al., 2020</xref>). PSMD values in probable-CAA and cSVD subjects from our study are comparable to those previously reported in other cSVD samples: CADASIL (4.5–5.47 × 10<sup>4</sup> mm<sup>2</sup>/s) (<xref rid="B4" ref-type="bibr">Baykara et al., 2016</xref>; <xref rid="B49" ref-type="bibr">Vinciguerra et al., 2018</xref>), memory-clinic subjects with sporadic cSVD (4.24 × 10<sup>4</sup> mm<sup>2</sup>/s)(<xref rid="B4" ref-type="bibr">Baykara et al., 2016</xref>), and subjects with WM lesions and VCID (4.51 × 10<sup>4</sup> mm<sup>2</sup>/s) (<xref rid="B55" ref-type="bibr">Wei et al., 2019</xref>). <xref rid="B25" ref-type="bibr">McCreary et al. (2020)</xref> reported slightly higher PSMD among 34 CAA subjects (4.97 × 10<sup>4</sup> mm<sup>2</sup>/s), which could be explained by the presence of symptomatic ICH in that cohort. As expected, like other DTI-based techniques, global PSMD values are similar across different cSVD phenotypes and do not appear specific to any WM disease.</p><p>Though PSMD was originally developed as a global measure of WM integrity, our study supports that it can be successfully applied in a spatially oriented way, opening up interesting research possibilities. Expanding on existing research (<xref rid="B5" ref-type="bibr">Beaudet et al., 2020</xref>; <xref rid="B23" ref-type="bibr">Low et al., 2020</xref>), we calculated lobe-specific measures of PSMD, investigating between-group differences. We found that the degree to which PSMD values increased posteriorly was higher among probable-CAA compared to non-cSVD and cSVD subjects, indicating that there is a significant interaction between diagnosis and anteroposterior PSMD variations. The higher occipital-frontal PSMD gradients observed in the probable-CAA sample suggest that WM microstructural damage may be more severe in the posterior areas of the brain. This is consistent with several histopathological (<xref rid="B50" ref-type="bibr">Vinters and Gilbert, 1983</xref>; <xref rid="B46" ref-type="bibr">van Veluw et al., 2019a</xref>) and imaging (<xref rid="B39" ref-type="bibr">Smith et al., 2004</xref>; <xref rid="B32" ref-type="bibr">Rosand et al., 2005</xref>; <xref rid="B42" ref-type="bibr">Thanprasertsuk et al., 2014</xref>; <xref rid="B36" ref-type="bibr">Schouten et al., 2019</xref>) studies showing a posterior predilection of CAA pathology. This finding reflects a pattern of brain injury consistent with vascular amyloid deposition and could potentially provide insights into the predominant type of underlying microvascular pathology. Interestingly, we did not observe similar findings with MD or FA. That is, occipital-frontal MD and FA gradients did not differ between the groups. We also did not observe a significant interaction between region and group on these classical DTI metrics. Only PSMD displayed a spatial variation in line with the expected anteroposterior gradient of CAA pathology. This finding implies that different DTI metrics could show different sensitivity to underlying pathological changes, and could help explain their contrasting cognitive associations.</p><p>To further assess whether PSMD captures similar tissue abnormalities compared to average MD and FA, we investigated the relationship between conventional MRI markers of cSVD and each DTI metric. While PSMD is mainly associated with nWMHV, MD and FA strongly correlate with other markers, especially with PVS. Importantly, average MD and FA are central tendency measures, whereas PSMD is a dispersion metric (<xref rid="B5" ref-type="bibr">Beaudet et al., 2020</xref>). This difference could potentially explain the distinct neuroimaging associations observed. Furthermore, the degree to which these markers are influenced by specific technical parameters from the DTI protocol, such as the b-value, is uncertain and could potentially impact their ability to detect specific underlying tissue changes (<xref rid="B17" ref-type="bibr">Hui et al., 2010</xref>). The strong associations between PVS and classical DTI metrics align with recent observations that MD and FA changes in cSVD are mainly driven by increased water content in the extracellular compartment (named free-water), which includes the perivascular space (<xref rid="B12" ref-type="bibr">Duering et al., 2018</xref>). The exclusive and robust relationship between PSMD and non-hemorrhagic markers of cSVD, especially with WMH, has also been reported before (<xref rid="B25" ref-type="bibr">McCreary et al., 2020</xref>; <xref rid="B29" ref-type="bibr">Raposo et al., 2021</xref>). Ischemic markers are thought to cause structural disruption beyond the core lesions (<xref rid="B48" ref-type="bibr">van Veluw et al., 2017</xref>) and have been consistently associated with different DTI measures (<xref rid="B3" ref-type="bibr">Auriel et al., 2014</xref>; <xref rid="B30" ref-type="bibr">Reijmer et al., 2015a</xref>) and with cognitive function (<xref rid="B45" ref-type="bibr">van Dalen et al., 2015</xref>) in other cohorts.</p><p>Other DWI-based measures, like FA, apparent diffusion coefficient, and brain network measures, have been linked to loss of microstructural integrity in CAA (<xref rid="B33" ref-type="bibr">Salat et al., 2006</xref>; <xref rid="B52" ref-type="bibr">Viswanathan et al., 2008</xref>; <xref rid="B30" ref-type="bibr">Reijmer et al., 2015a</xref>), and some were also associated with cognitive performance (<xref rid="B52" ref-type="bibr">Viswanathan et al., 2008</xref>; <xref rid="B30" ref-type="bibr">Reijmer et al., 2015a</xref>; <xref rid="B25" ref-type="bibr">McCreary et al., 2020</xref>). Among these, only brain network analysis has been shown to reflect the anteroposterior gradient of CAA pathology, and, interestingly, it correlated with the same cognitive domains as PSMD (executive function and processing speed) (<xref rid="B30" ref-type="bibr">Reijmer et al., 2015a</xref>). These domains are commonly affected in VCID, which could imply that vascular pathology is likely the primary mechanism involved in the diffusion abnormalities captured by PSMD. Though it has been advocated that PSMD could be a specific or exclusive marker of processing speed (<xref rid="B37" ref-type="bibr">Smith and Beaudin, 2018</xref>), more recent studies with cSVD samples (<xref rid="B55" ref-type="bibr">Wei et al., 2019</xref>) and population-based cohorts (<xref rid="B11" ref-type="bibr">Deary et al., 2019</xref>; <xref rid="B23" ref-type="bibr">Low et al., 2020</xref>) found associations with other cognitive domains. It is noteworthy that PSMD outperformed both conventional and diffusion-based MRI markers of cSVD in our CAA cohort, which is consistent with findings from other groups (<xref rid="B4" ref-type="bibr">Baykara et al., 2016</xref>). Interestingly, in an exploratory analysis, while frontal PSMD values correlated with cognitive performance, occipital PSMD values did not. It is possible that frontal areas could be driving the associations observed between global PSMD and executive function/processing speed. This interpretation is in line with studies that support a central role of frontal regions, such as the dorsolateral prefrontal cortex, in orchestrating executive functions (<xref rid="B26" ref-type="bibr">Panikratova et al., 2020</xref>). Most conventional markers did not correlate with cognition in our sample, adding to their previously reported weak and inconsistent associations (<xref rid="B31" ref-type="bibr">Reijmer et al., 2015b</xref>). Though average MD and FA were not associated with cognition in our CAA sample, <xref rid="B25" ref-type="bibr">McCreary et al. (2020)</xref> found MD values to be associated with processing speed (<italic toggle="yes">p</italic> = 0.004) in a smaller sample of CAA patients. These conflicting results could potentially be due to the presence of symptomatic ICH in the Canadian cohort, which could significantly impact MD values and their cognitive associations.</p><p>Importantly, PSMD’s histopathological correlates have not yet been investigated. <xref rid="B47" ref-type="bibr">van Veluw et al. (2019b)</xref> found, in an <italic toggle="yes">ex vivo</italic> study of CAA patients, that MD values correlate with tissue rarefaction, myelin density, and WM microinfarcts. PSMD and mean MD values are both increased in CAA subjects and could reflect somewhat similar histopathological changes (<xref rid="B25" ref-type="bibr">McCreary et al., 2020</xref>). However, the distinct neuroimaging associations and spatial variation patterns observed between PSMD, and classical DTI metrics raise the possibility that they might be capturing slightly different histopathological abnormalities. Therefore, future studies investigating PSMD’s histological correlates are warranted and could improve the interpretation and biological understanding of this new and promising marker.</p><p>Our study has limitations. First, the cross-sectional design limits causal inference, calling for future longitudinal studies. Second, in this single-center study, we included only non-demented subjects from a memory-clinic setting, which accounts for a very specific CAA-profile and limits generalizability. Nonetheless, we chose to restrict recruitment from stroke-center subjects to avoid combining different phenotypes of CAA (<xref rid="B7" ref-type="bibr">Charidimou et al., 2015</xref>) in the same sample. By excluding demented patients, we aimed to capture earlier steps in the evolution of CAA and reduce the influence of concomitant AD pathology in our findings. The unavailability of cerebral spinal fluid (CSF) and positron emission tomography (PET) markers precluded a more detailed etiological characterization of the groups, based solely on MRI criteria.</p></sec><sec sec-type="conclusion" id="S5"><title>Conclusion</title><p>In conclusion, we provided evidence on PSMD’s promising role as a measure of both global and regional WM injury in CAA. Although global PSMD values are similarly increased in different forms of cSVD, regional PSMD analyses may capture disease-specific spatial variations. PSMD outperforms conventional and DTI-based markers as a cognitive biomarker in CAA and shows a distinct profile of neuroimaging correlates compared to MD and FA. Future research should investigate PSMD’s histopathological correlates and its performance in larger multi-center longitudinal CAA cohorts.</p></sec><sec sec-type="data-availability" id="S6"><title>Data availability statement</title><p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></sec><sec id="S7"><title>Ethics statement</title><p>The studies involving human participants were reviewed and approved by the Institutional Review Board of the Massachusetts General Hospital (MGH). The patients/participants provided their written informed consent to participate in this study.</p></sec><sec id="S8"><title>Author contributions</title><p>MZ: study concept or design, major role in the acquisition of data, analysis or interpretation of data, and drafting/revision of the manuscript. DS: major role in the acquisition of data, analysis or interpretation of data, and drafting/revision of the manuscript. MH: major role in the acquisition of data and drafting/revision of the manuscript. NR, VP, MB, LS, QL, SV, ME, AC, MG, MD, AS, and OP-N: analysis or interpretation of data and drafting/revision of the manuscript. AV: study concept or design, analysis or interpretation of data, and drafting/revision of the manuscript. All authors contributed to the article and approved the submitted version.</p></sec></body><back><sec sec-type="funding-information" id="S9"><title>Funding</title><p>This study was supported by the following NIH grants: R01AG047975, R01AG026484, P50AG005134, and K23AG02872605. LS was supported by the Swiss National Science Foundation Postdoctoral Scholarship (P2GEP3_191584). MB was supported by the ISITE-ULNE Foundation, the Société Franc̨aise de Neuroradiologie, the Société Franc̨aise de Radiologie, and the Thérèse and René Planiol Foundation.</p></sec><fn-group><fn id="footnote1"><label>1</label><p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.psmd-marker.com" ext-link-type="uri">http://www.psmd-marker.com</ext-link>
</p></fn><fn id="footnote2"><label>2</label><p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://surfer.nmr.mgh.harvard.edu" ext-link-type="uri">https://surfer.nmr.mgh.harvard.edu</ext-link>
</p></fn><fn id="footnote3"><label>3</label><p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.statistical-modelling.de/lst.html" ext-link-type="uri">www.statistical-modelling.de/lst.html</ext-link>
</p></fn></fn-group><sec sec-type="COI-statement" id="S10"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="S11"><title>Publisher’s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><sec sec-type="supplementary-material" id="S12"><title>Supplementary material</title><p>The Supplementary Material for this article can be found online at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.frontiersin.org/articles/10.3389/fnins.2022.1051038/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fnins.2022.1051038/full#supplementary-material</ext-link></p><supplementary-material id="TS1" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table_1.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="TS2" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table_2.DOCX" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="TS3" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table_3.DOCX" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andersson</surname><given-names>J. L. R.</given-names></name><name name-style="western"><surname>Sotiropoulos</surname><given-names>S. N.</given-names></name></person-group> (<year>2015</year>). <article-title>Non-parametric representation and prediction of single- and multi-shell diffusion-weighted MRI data using gaussian processes.</article-title><source><italic toggle="yes">Neuroimage</italic></source><volume>122</volume><fpage>166</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2015.07.067</pub-id><pub-id pub-id-type="pmid">26236030</pub-id><pub-id pub-id-type="pmcid">PMC4627362</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arvanitakis</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Leurgans</surname><given-names>S. E.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>R. S.</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>J. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Cerebral amyloid angiopathy pathology and cognitive domains in older persons.</article-title><source><italic toggle="yes">Ann. Neurol.</italic></source><volume>69</volume><fpage>320</fpage>–<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22112</pub-id><pub-id pub-id-type="pmid">21387377</pub-id><pub-id pub-id-type="pmcid">PMC3228518</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Auriel</surname><given-names>E.</given-names></name><name name-style="western"><surname>Edlow</surname><given-names>B. L.</given-names></name><name name-style="western"><surname>Reijmer</surname><given-names>Y. D.</given-names></name><name name-style="western"><surname>Fotiadis</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ramirez-Martinez</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ni</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Microinfarct disruption of white matter structure.</article-title><source><italic toggle="yes">Neurology</italic></source><volume>83</volume><fpage>182</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.0000000000000579</pub-id><pub-id pub-id-type="pmid">24920857</pub-id><pub-id pub-id-type="pmcid">PMC4117171</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baykara</surname><given-names>E.</given-names></name><name name-style="western"><surname>Gesierich</surname><given-names>B.</given-names></name><name name-style="western"><surname>Adam</surname><given-names>R.</given-names></name><name name-style="western"><surname>Tuladhar</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Biesbroek</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Koek</surname><given-names>H. L.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms.</article-title><source><italic toggle="yes">Ann. Neurol.</italic></source><volume>80</volume><fpage>581</fpage>–<lpage>592</lpage>. <pub-id pub-id-type="doi">10.1002/ana.24758</pub-id><pub-id pub-id-type="pmid">27518166</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beaudet</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tsuchida</surname><given-names>A.</given-names></name><name name-style="western"><surname>Petit</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tzourio</surname><given-names>C.</given-names></name><name name-style="western"><surname>Caspers</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schreiber</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Age-related changes of peak width skeletonized mean diffusivity (PSMD) across the adult lifespan: A multi-cohort study.</article-title><source><italic toggle="yes">Front. Psychiatry</italic></source><volume>11</volume>:<issue>342</issue>. <pub-id pub-id-type="doi">10.3389/fpsyt.2020.00342</pub-id><pub-id pub-id-type="pmid">32425831</pub-id><pub-id pub-id-type="pmcid">PMC7212692</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brandt</surname><given-names>J.</given-names></name></person-group> (<year>1991</year>). <article-title>The hopkins verbal learning test: Development of a new memory test with six equivalent forms.</article-title><source><italic toggle="yes">Clin. Neuropsychol.</italic></source><volume>5</volume><fpage>125</fpage>–<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1080/13854049108403297</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Charidimou</surname><given-names>A.</given-names></name><name name-style="western"><surname>Martinez-Ramirez</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shoamanesh</surname><given-names>A.</given-names></name><name name-style="western"><surname>Oliveira-Filho</surname><given-names>J.</given-names></name><name name-style="western"><surname>Frosch</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vashkevich</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Cerebral amyloid angiopathy with and without hemorrhage.</article-title><source><italic toggle="yes">Neurology</italic></source><volume>84</volume><fpage>1206</fpage>–<lpage>1212</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.0000000000001398</pub-id><pub-id pub-id-type="pmid">25716356</pub-id><pub-id pub-id-type="pmcid">PMC4366086</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corrigan</surname><given-names>J. D.</given-names></name><name name-style="western"><surname>Hinkeldey</surname><given-names>N. S.</given-names></name></person-group> (<year>1987</year>). <article-title>Relationships between parts a and b of the trail making test.</article-title><source><italic toggle="yes">J. Clin. Psychol.</italic></source><volume>43</volume><fpage>402</fpage>–<lpage>409</lpage>. <pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1097-4679(198707)43:4&amp;#x0003c;402::aid-jclp2270430411&amp;#x0003e;3.0.co;2-e</pub-id><pub-id pub-id-type="pmid">3611374</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crum</surname><given-names>R. M.</given-names></name><name name-style="western"><surname>Anthony</surname><given-names>J. C.</given-names></name><name name-style="western"><surname>Bassett</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>Folstein</surname><given-names>M. F.</given-names></name></person-group> (<year>1993</year>). <article-title>Population-based norms for the mini-mental state examination by age and educational level.</article-title><source><italic toggle="yes">JAMA</italic></source><volume>269</volume><fpage>2386</fpage>–<lpage>2391</lpage>. <pub-id pub-id-type="doi">10.1001/jama.1993.03500180078038</pub-id><pub-id pub-id-type="pmid">8479064</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dale</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Fischl</surname><given-names>B.</given-names></name><name name-style="western"><surname>Sereno</surname><given-names>M. I.</given-names></name></person-group> (<year>1999</year>). <article-title>Cortical surface-based analysis I. segmentation and surface reconstruction.</article-title><source><italic toggle="yes">Neuroimage</italic></source><volume>9</volume><fpage>179</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1006/nimg.1998.0395</pub-id><pub-id pub-id-type="pmid">9931268</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deary</surname><given-names>I. J.</given-names></name><name name-style="western"><surname>Ritchie</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Maniega</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Cox</surname><given-names>S. R.</given-names></name><name name-style="western"><surname>Hernández</surname><given-names>M. C. V.</given-names></name><name name-style="western"><surname>Luciano</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Brain peak width of skeletonized mean diffusivity (PSMD) and cognitive function in later life.</article-title><source><italic toggle="yes">Front. Psychiatry</italic></source><volume>10</volume>:<issue>524</issue>. <pub-id pub-id-type="doi">10.3389/fpsyt.2019.00524</pub-id><pub-id pub-id-type="pmid">31402877</pub-id><pub-id pub-id-type="pmcid">PMC6676305</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duering</surname><given-names>M.</given-names></name><name name-style="western"><surname>Finsterwalder</surname><given-names>S.</given-names></name><name name-style="western"><surname>Baykara</surname><given-names>E.</given-names></name><name name-style="western"><surname>Tuladhar</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Gesierich</surname><given-names>B.</given-names></name><name name-style="western"><surname>Konieczny</surname><given-names>M. J.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Free water determines diffusion alterations and clinical status in cerebral small vessel disease.</article-title><source><italic toggle="yes">Alzheimer’s Dement.</italic></source><volume>14</volume><fpage>764</fpage>–<lpage>774</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2017.12.007</pub-id><pub-id pub-id-type="pmid">29406155</pub-id><pub-id pub-id-type="pmcid">PMC5994358</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fastenau</surname><given-names>P. S.</given-names></name><name name-style="western"><surname>Denburg</surname><given-names>N. L.</given-names></name><name name-style="western"><surname>Mauer</surname><given-names>B. A.</given-names></name></person-group> (<year>1998</year>). <article-title>Parallel short forms for the Boston naming test: Psychometric properties and norms for older adults.</article-title><source><italic toggle="yes">J. Clin. Exp. Neuropsychol.</italic></source><volume>20</volume><fpage>828</fpage>–<lpage>834</lpage>. <pub-id pub-id-type="doi">10.1076/jcen.20.6.828.1105</pub-id><pub-id pub-id-type="pmid">10484693</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fazekas</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chawluk</surname><given-names>J.</given-names></name><name name-style="western"><surname>Alavi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hurtig</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zimmerman</surname><given-names>R.</given-names></name></person-group> (<year>1987</year>). <article-title>MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging.</article-title><source><italic toggle="yes">Am. J. Roentgenol.</italic></source><volume>149</volume><fpage>351</fpage>–<lpage>356</lpage>. <pub-id pub-id-type="doi">10.2214/ajr.149.2.351</pub-id><pub-id pub-id-type="pmid">3496763</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finsterwalder</surname><given-names>S.</given-names></name><name name-style="western"><surname>Vlegels</surname><given-names>N.</given-names></name><name name-style="western"><surname>Gesierich</surname><given-names>B.</given-names></name><name name-style="western"><surname>Caballero</surname><given-names>M. ÁA.</given-names></name><name name-style="western"><surname>Weaver</surname><given-names>N. A.</given-names></name><name name-style="western"><surname>Franzmeier</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Small vessel disease more than alzheimer’s disease determines diffusion MRI alterations in memory clinic patients.</article-title><source><italic toggle="yes">Alzheimer’s Dement.</italic></source><volume>16</volume><fpage>1504</fpage>–<lpage>1514</lpage>. <pub-id pub-id-type="doi">10.1002/alz.12150</pub-id><pub-id pub-id-type="pmid">32808747</pub-id><pub-id pub-id-type="pmcid">PMC8102202</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grömping</surname><given-names>U.</given-names></name></person-group> (<year>2006</year>). <article-title>Relative importance for linear regression in R : The package relaimpo.</article-title><source><italic toggle="yes">J. Stat. Softw.</italic></source><volume>17</volume><fpage>1</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.18637/jss.v017.i01</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hui</surname><given-names>E. S.</given-names></name><name name-style="western"><surname>Cheung</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>K. C.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>E. X.</given-names></name></person-group> (<year>2010</year>). <article-title>B-value dependence of DTI quantitation and sensitivity in detecting neural tissue changes.</article-title><source><italic toggle="yes">Neuroimage</italic></source><volume>49</volume><fpage>2366</fpage>–<lpage>2374</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2009.10.022</pub-id><pub-id pub-id-type="pmid">19837181</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jenkinson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Beckmann</surname><given-names>C. F.</given-names></name><name name-style="western"><surname>Behrens</surname><given-names>T. E. J.</given-names></name><name name-style="western"><surname>Woolrich</surname><given-names>M. W.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>S. M.</given-names></name></person-group> (<year>2012</year>). <article-title>FSL.</article-title><source><italic toggle="yes">Neuroimage</italic></source><volume>62</volume><fpage>782</fpage>–<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.09.015</pub-id><pub-id pub-id-type="pmid">21979382</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joy</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>E.</given-names></name><name name-style="western"><surname>Fein</surname><given-names>D.</given-names></name></person-group> (<year>2004</year>). <article-title>Speed and memory in the WAIS-III digit symbol—coding subtest across the adult lifespan.</article-title><source><italic toggle="yes">Arch. Clin. Neuropsychol.</italic></source><volume>19</volume><fpage>759</fpage>–<lpage>767</lpage>. <pub-id pub-id-type="doi">10.1016/j.acn.2003.09.009</pub-id><pub-id pub-id-type="pmid">15288329</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lam</surname><given-names>B. Y. K.</given-names></name><name name-style="western"><surname>Leung</surname><given-names>K. T.</given-names></name><name name-style="western"><surname>Yiu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Biesbroek</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Au</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Peak width of skeletonized mean diffusivity and its association with age-related cognitive alterations and vascular risk factors.</article-title><source><italic toggle="yes">Alzheimer’s Dement. Diagn. Assess. Dis. Monit.</italic></source><volume>11</volume><fpage>721</fpage>–<lpage>729</lpage>. <pub-id pub-id-type="doi">10.1016/j.dadm.2019.09.003</pub-id><pub-id pub-id-type="pmid">31700990</pub-id><pub-id pub-id-type="pmcid">PMC6829102</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Lindeman</surname><given-names>R. H.</given-names></name><name name-style="western"><surname>Merenda</surname><given-names>P. F.</given-names></name><name name-style="western"><surname>Gold</surname><given-names>R. Z.</given-names></name></person-group> (<year>1980</year>). <source><italic toggle="yes">Introduction to Bivariate and Multivariate Analysis.</italic></source><publisher-loc>Northbrook</publisher-loc>: <publisher-name>Foresman</publisher-name>.</mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linn</surname><given-names>J.</given-names></name><name name-style="western"><surname>Halpin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Demaerel</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ruhland</surname><given-names>J.</given-names></name><name name-style="western"><surname>Giese</surname><given-names>A. D.</given-names></name><name name-style="western"><surname>Dichgans</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy.</article-title><source><italic toggle="yes">Neurology</italic></source><volume>74</volume><fpage>1346</fpage>–<lpage>1350</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.0b013e3181dad605</pub-id><pub-id pub-id-type="pmid">20421578</pub-id><pub-id pub-id-type="pmcid">PMC2875936</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Low</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mak</surname><given-names>E.</given-names></name><name name-style="western"><surname>Stefaniak</surname><given-names>J. D.</given-names></name><name name-style="western"><surname>Malpetti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nicastro</surname><given-names>N.</given-names></name><name name-style="western"><surname>Savulich</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Peak width of skeletonized mean diffusivity as a marker of diffuse cerebrovascular damage.</article-title><source><italic toggle="yes">Front. Neurosci.</italic></source><volume>14</volume>:<issue>238</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2020.00238</pub-id><pub-id pub-id-type="pmid">32265640</pub-id><pub-id pub-id-type="pmcid">PMC7096698</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mack</surname><given-names>W. J.</given-names></name><name name-style="western"><surname>Freed</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>B. W.</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>V. W.</given-names></name></person-group> (<year>1992</year>). <article-title>Boston naming test: Shortened versions for use in alzheimer’s disease.</article-title><source><italic toggle="yes">J. Gerontol.</italic></source><volume>47</volume><fpage>154</fpage>–<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1093/geronj/47.3.p154</pub-id><pub-id pub-id-type="pmid">1573197</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCreary</surname><given-names>C. R.</given-names></name><name name-style="western"><surname>Beaudin</surname><given-names>A. E.</given-names></name><name name-style="western"><surname>Subotic</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zwiers</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Alvarez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Charlton</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy.</article-title><source><italic toggle="yes">Neuroimage Clin.</italic></source><volume>27</volume>:<issue>102280</issue>. <pub-id pub-id-type="doi">10.1016/j.nicl.2020.102280</pub-id><pub-id pub-id-type="pmid">32521475</pub-id><pub-id pub-id-type="pmcid">PMC7284130</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panikratova</surname><given-names>Y. R.</given-names></name><name name-style="western"><surname>Vlasova</surname><given-names>R. M.</given-names></name><name name-style="western"><surname>Akhutina</surname><given-names>T. V.</given-names></name><name name-style="western"><surname>Korneev</surname><given-names>A. A.</given-names></name><name name-style="western"><surname>Sinitsyn</surname><given-names>V. E.</given-names></name><name name-style="western"><surname>Pechenkova</surname><given-names>E. V.</given-names></name></person-group> (<year>2020</year>). <article-title>Functional connectivity of the dorsolateral prefrontal cortex contributes to different components of executive functions</article-title>. <source><italic toggle="yes">Int. J. Psychophysiol.</italic></source><volume>151</volume>, <fpage>70</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpsycho.2020.02.013</pub-id><pub-id pub-id-type="pmid">32109499</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pasi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Charidimou</surname><given-names>A.</given-names></name><name name-style="western"><surname>Boulouis</surname><given-names>G.</given-names></name><name name-style="western"><surname>Auriel</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ayres</surname><given-names>A.</given-names></name><name name-style="western"><surname>Schwab</surname><given-names>K. M.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Mixed-location cerebral hemorrhage/microbleeds.</article-title><source><italic toggle="yes">Neurology</italic></source><volume>90</volume>:<fpage>e119</fpage>–<lpage>e126</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.0000000000004797</pub-id><pub-id pub-id-type="pmid">29247070</pub-id><pub-id pub-id-type="pmcid">PMC5772153</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Potter</surname><given-names>G. M.</given-names></name><name name-style="western"><surname>Chappell</surname><given-names>F. M.</given-names></name><name name-style="western"><surname>Morris</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Wardlaw</surname><given-names>J. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Cerebral perivascular spaces visible on magnetic resonance imaging: Development of a qualitative rating scale and its observer reliability.</article-title><source><italic toggle="yes">Cerebrovasc. Dis.</italic></source><volume>39</volume><fpage>224</fpage>–<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1159/000375153</pub-id><pub-id pub-id-type="pmid">25823458</pub-id><pub-id pub-id-type="pmcid">PMC4386144</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raposo</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zotin</surname><given-names>M. C. Z.</given-names></name><name name-style="western"><surname>Schoemaker</surname><given-names>D.</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Fotiadis</surname><given-names>P.</given-names></name><name name-style="western"><surname>Charidimou</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Peak width of skeletonized mean diffusivity as neuroimaging biomarker in cerebral amyloid angiopathy.</article-title><source><italic toggle="yes">Am. J. Neuroradiol</italic>.</source><volume>42</volume><fpage>875</fpage>–<lpage>881</lpage>. <pub-id pub-id-type="doi">10.3174/ajnr.a7042</pub-id><pub-id pub-id-type="pmid">33664113</pub-id><pub-id pub-id-type="pmcid">PMC8115367</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reijmer</surname><given-names>Y. D.</given-names></name><name name-style="western"><surname>Fotiadis</surname><given-names>P.</given-names></name><name name-style="western"><surname>Martinez-Ramirez</surname><given-names>S.</given-names></name><name name-style="western"><surname>Salat</surname><given-names>D. H.</given-names></name><name name-style="western"><surname>Schultz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Shoamanesh</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2015a</year>). <article-title>Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy.</article-title><source><italic toggle="yes">Brain</italic></source><volume>138</volume><fpage>179</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awu316</pub-id><pub-id pub-id-type="pmid">25367025</pub-id><pub-id pub-id-type="pmcid">PMC4285191</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reijmer</surname><given-names>Y. D.</given-names></name><name name-style="western"><surname>van Veluw</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Greenberg</surname><given-names>S. M.</given-names></name></person-group> (<year>2015b</year>). <article-title>Ischemic brain injury in cerebral amyloid angiopathy.</article-title><source><italic toggle="yes">J. Cereb. Blood Flow Metab.</italic></source><volume>36</volume><fpage>40</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2015.88</pub-id><pub-id pub-id-type="pmid">25944592</pub-id><pub-id pub-id-type="pmcid">PMC4758563</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosand</surname><given-names>J.</given-names></name><name name-style="western"><surname>Muzikansky</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wisco</surname><given-names>J. J.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>E. E.</given-names></name><name name-style="western"><surname>Betensky</surname><given-names>R. A.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy.</article-title><source><italic toggle="yes">Ann. Neurol.</italic></source><volume>58</volume><fpage>459</fpage>–<lpage>462</lpage>. <pub-id pub-id-type="doi">10.1002/ana.20596</pub-id><pub-id pub-id-type="pmid">16130107</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salat</surname><given-names>D. H.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>E. E.</given-names></name><name name-style="western"><surname>Tuch</surname><given-names>D. S.</given-names></name><name name-style="western"><surname>Benner</surname><given-names>T.</given-names></name><name name-style="western"><surname>Pappu</surname><given-names>V.</given-names></name><name name-style="western"><surname>Schwab</surname><given-names>K. M.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>White matter alterations in cerebral amyloid angiopathy measured by diffusion tensor imaging.</article-title><source><italic toggle="yes">Stroke</italic></source><volume>37</volume><fpage>1759</fpage>–<lpage>1764</lpage>. <pub-id pub-id-type="doi">10.1161/01.str.0000227328.86353.a7</pub-id><pub-id pub-id-type="pmid">16763176</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sánchez-Cubillo</surname><given-names>I.</given-names></name><name name-style="western"><surname>Periáñez</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Adrover-Roig</surname><given-names>D.</given-names></name><name name-style="western"><surname>Rodríguez-Sánchez</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Ríos-Lago</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tirapu</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Construct validity of the trail making test: Role of task-switching, working memory, inhibition/interference control, and visuomotor abilities.</article-title><source><italic toggle="yes">J. Int. Neuropsychol. Soc.</italic></source><volume>15</volume><fpage>438</fpage>–<lpage>450</lpage>. <pub-id pub-id-type="doi">10.1017/s1355617709090626</pub-id><pub-id pub-id-type="pmid">19402930</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>P.</given-names></name></person-group> (<year>2017</year>). <source><italic toggle="yes">Bayesian Inference For Structured Additive Regression Models For Large-Scale Problems With Applications To Medical Imaging</italic></source>, <comment>Ph.D thesis</comment>, <publisher-loc>München</publisher-loc>: <publisher-name>Universitätsbibliothek der Ludwig-Maximilians-Universität</publisher-name>.</mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schouten</surname><given-names>T. M.</given-names></name><name name-style="western"><surname>de Vos</surname><given-names>F.</given-names></name><name name-style="western"><surname>van Rooden</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bouts</surname><given-names>M. J. R. J.</given-names></name><name name-style="western"><surname>van Opstal</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Feis</surname><given-names>R. A.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Multiple approaches to diffusion magnetic resonance imaging in hereditary cerebral amyloid angiopathy mutation carriers.</article-title><source><italic toggle="yes">J. Am. Heart Assoc.</italic></source><volume>8</volume>:<issue>e011288</issue>. <pub-id pub-id-type="doi">10.1161/jaha.118.011288</pub-id><pub-id pub-id-type="pmid">30717612</pub-id><pub-id pub-id-type="pmcid">PMC6405585</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>E. E.</given-names></name><name name-style="western"><surname>Beaudin</surname><given-names>A. E.</given-names></name></person-group> (<year>2018</year>). <article-title>New insights into cerebral small vessel disease and vascular cognitive impairment from MRI.</article-title><source><italic toggle="yes">Curr. Opin. Neurol.</italic></source><volume>31</volume><fpage>36</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1097/wco.0000000000000513</pub-id><pub-id pub-id-type="pmid">29084064</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>E. E.</given-names></name><name name-style="western"><surname>Biessels</surname><given-names>G. J.</given-names></name><name name-style="western"><surname>Guio</surname><given-names>F. D.</given-names></name><name name-style="western"><surname>Leeuw</surname><given-names>F. E.</given-names></name><name name-style="western"><surname>Duchesne</surname><given-names>S.</given-names></name><name name-style="western"><surname>Düring</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration.</article-title><source><italic toggle="yes">Alzheimer’s Dement. Diagn. Assess. Dis. Monit.</italic></source><volume>11</volume><fpage>191</fpage>–<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/j.dadm.2019.01.002</pub-id><pub-id pub-id-type="pmid">30859119</pub-id><pub-id pub-id-type="pmcid">PMC6396326</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>E. E.</given-names></name><name name-style="western"><surname>Gurol</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>Eng</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Engel</surname><given-names>C. R.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>T. N.</given-names></name><name name-style="western"><surname>Rosand</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage.</article-title><source><italic toggle="yes">Neurology</italic></source><volume>63</volume><fpage>1606</fpage>–<lpage>1612</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000142966.22886.20</pub-id><pub-id pub-id-type="pmid">15534243</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>S. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Fast robust automated brain extraction.</article-title><source><italic toggle="yes">Hum. Brain Mapp.</italic></source><volume>17</volume><fpage>143</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.10062</pub-id><pub-id pub-id-type="pmid">12391568</pub-id><pub-id pub-id-type="pmcid">PMC6871816</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Jenkinson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Johansen-Berg</surname><given-names>H.</given-names></name><name name-style="western"><surname>Rueckert</surname><given-names>D.</given-names></name><name name-style="western"><surname>Nichols</surname><given-names>T. E.</given-names></name><name name-style="western"><surname>Mackay</surname><given-names>C. E.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data.</article-title><source><italic toggle="yes">Neuroimage</italic></source><volume>31</volume><fpage>1487</fpage>–<lpage>1505</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2006.02.024</pub-id><pub-id pub-id-type="pmid">16624579</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thanprasertsuk</surname><given-names>S.</given-names></name><name name-style="western"><surname>Martinez-Ramirez</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pontes-Neto</surname><given-names>O. M.</given-names></name><name name-style="western"><surname>Ni</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ayres</surname><given-names>A.</given-names></name><name name-style="western"><surname>Reed</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Posterior white matter disease distribution as a predictor of amyloid angiopathy.</article-title><source><italic toggle="yes">Neurology</italic></source><volume>83</volume><fpage>794</fpage>–<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.0000000000000732</pub-id><pub-id pub-id-type="pmid">25063759</pub-id><pub-id pub-id-type="pmcid">PMC4155043</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tombaugh</surname><given-names>T. N.</given-names></name></person-group> (<year>2004</year>). <article-title>Trail making test A and B: Normative data stratified by age and education.</article-title><source><italic toggle="yes">Arch. Clin. Neuropsychol.</italic></source><volume>19</volume><fpage>203</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1016/s0887-6177(03)00039-8</pub-id><pub-id pub-id-type="pmid">15010086</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tombaugh</surname><given-names>T. N.</given-names></name><name name-style="western"><surname>Kozak</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rees</surname><given-names>L.</given-names></name></person-group> (<year>1999</year>). <article-title>Normative data stratified by age and education for two measures of verbal fluency fas and animal naming.</article-title><source><italic toggle="yes">Arch. Clin. Neuropsychol.</italic></source><volume>14</volume><fpage>167</fpage>–<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1016/s0887-6177(97)00095-4</pub-id><pub-id pub-id-type="pmid">14590600</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Dalen</surname><given-names>J. W.</given-names></name><name name-style="western"><surname>Scuric</surname><given-names>E. E. M.</given-names></name><name name-style="western"><surname>Veluw</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>van</surname></name><name name-style="western"><surname>Caan</surname><given-names>M. W. A.</given-names></name><name name-style="western"><surname>Nederveen</surname><given-names>A. J.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Cortical microinfarcts detected <italic toggle="yes">in vivo</italic> on 3 tesla MRI.</article-title><source><italic toggle="yes">Stroke</italic></source><volume>46</volume><fpage>255</fpage>–<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1161/strokeaha.114.007568</pub-id><pub-id pub-id-type="pmid">25468879</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Veluw</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Scherlek</surname><given-names>A. A.</given-names></name><name name-style="western"><surname>Freeze</surname><given-names>W. M.</given-names></name><name name-style="western"><surname>Telgte</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kouwe</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Bacskai</surname><given-names>B. J.</given-names></name><etal/></person-group> (<year>2019a</year>). <article-title>Different microvascular alterations underlie microbleeds and microinfarcts.</article-title><source><italic toggle="yes">Ann. Neurol.</italic></source><volume>86</volume><fpage>279</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1002/ana.25512</pub-id><pub-id pub-id-type="pmid">31152566</pub-id><pub-id pub-id-type="pmcid">PMC8722100</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Veluw</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Reijmer</surname><given-names>Y. D.</given-names></name><name name-style="western"><surname>van der Kouwe</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Charidimou</surname><given-names>A.</given-names></name><name name-style="western"><surname>Riley</surname><given-names>G. A.</given-names></name><name name-style="western"><surname>Leemans</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2019b</year>). <article-title>Histopathology of diffusion imaging abnormalities in cerebral amyloid angiopathy.</article-title><source><italic toggle="yes">Neurology</italic></source><volume>92</volume>:<fpage>e933</fpage>–<lpage>e943</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.0000000000007005</pub-id><pub-id pub-id-type="pmid">30700595</pub-id><pub-id pub-id-type="pmcid">PMC6404469</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Veluw</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Shih</surname><given-names>A. Y.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>E. E.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Wardlaw</surname><given-names>J. M.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Detection, risk factors, and functional consequences of cerebral microinfarcts.</article-title><source><italic toggle="yes">Lancet Neurol.</italic></source><volume>16</volume><fpage>730</fpage>–<lpage>740</lpage>. <pub-id pub-id-type="doi">10.1016/s1474-4422(17)30196-5</pub-id><pub-id pub-id-type="pmid">28716371</pub-id><pub-id pub-id-type="pmcid">PMC5861500</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vinciguerra</surname><given-names>C.</given-names></name><name name-style="western"><surname>Giorgio</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Donato</surname><given-names>I. D.</given-names></name><name name-style="western"><surname>Stromillo</surname><given-names>M. L.</given-names></name><name name-style="western"><surname>Brocci</surname><given-names>R. T.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis.</article-title><source><italic toggle="yes">Mult. Scler. Relat. Disord.</italic></source><volume>27</volume><fpage>294</fpage>–<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1016/j.msard.2018.11.011</pub-id><pub-id pub-id-type="pmid">30448470</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vinters</surname><given-names>H. V.</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>J. J.</given-names></name></person-group> (<year>1983</year>). <article-title>Cerebral amyloid angiopathy: Incidence and complications in the aging brain. II. The distribution of amyloid vascular changes.</article-title><source><italic toggle="yes">Stroke</italic></source><volume>14</volume><fpage>924</fpage>–<lpage>928</lpage>. <pub-id pub-id-type="doi">10.1161/01.str.14.6.924</pub-id><pub-id pub-id-type="pmid">6658996</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Viswanathan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Greenberg</surname><given-names>S. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Cerebral amyloid angiopathy in the elderly.</article-title><source><italic toggle="yes">Ann. Neurol.</italic></source><volume>70</volume><fpage>871</fpage>–<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22516</pub-id><pub-id pub-id-type="pmid">22190361</pub-id><pub-id pub-id-type="pmcid">PMC4004372</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Viswanathan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>P.</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>R.</given-names></name><name name-style="western"><surname>Nandigam</surname><given-names>R. N. K.</given-names></name><name name-style="western"><surname>Kinnecom</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bracoud</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy.</article-title><source><italic toggle="yes">Stroke</italic></source><volume>39</volume><fpage>1988</fpage>–<lpage>1992</lpage>. <pub-id pub-id-type="doi">10.1161/strokeaha.107.509091</pub-id><pub-id pub-id-type="pmid">18436874</pub-id><pub-id pub-id-type="pmcid">PMC2698787</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wardlaw</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>E. E.</given-names></name><name name-style="western"><surname>Biessels</surname><given-names>G. J.</given-names></name><name name-style="western"><surname>Cordonnier</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fazekas</surname><given-names>F.</given-names></name><name name-style="western"><surname>Frayne</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.</article-title><source><italic toggle="yes">Lancet Neurol.</italic></source><volume>12</volume><fpage>822</fpage>–<lpage>838</lpage>. <pub-id pub-id-type="doi">10.1016/s1474-4422(13)70124-8</pub-id><pub-id pub-id-type="pmid">23867200</pub-id><pub-id pub-id-type="pmcid">PMC3714437</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Wechsler</surname><given-names>D.</given-names></name></person-group> (<year>1987</year>). <source><italic toggle="yes">Wechsler Memory Scale-Revised Manual.</italic></source><publisher-loc>San Antonio</publisher-loc>: <publisher-name>The Psychological Corporation</publisher-name>.</mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>N.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>A neuroimaging marker based on diffusion tensor imaging and cognitive impairment due to cerebral white matter lesions.</article-title><source><italic toggle="yes">Front. Neurol.</italic></source><volume>10</volume>:<issue>81</issue>. <pub-id pub-id-type="doi">10.3389/fneur.2019.00081</pub-id><pub-id pub-id-type="pmid">30814973</pub-id><pub-id pub-id-type="pmcid">PMC6381840</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weintraub</surname><given-names>S.</given-names></name><name name-style="western"><surname>Salmon</surname><given-names>D.</given-names></name><name name-style="western"><surname>Mercaldo</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ferris</surname><given-names>S.</given-names></name><name name-style="western"><surname>Graff-Radford</surname><given-names>N. R.</given-names></name><name name-style="western"><surname>Chui</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>The alzheimer’s disease centers’ Uniform Data Set (UDS).</article-title><source><italic toggle="yes">Alzheimer Dis. Assoc. Disord.</italic></source><volume>23</volume><fpage>91</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1097/wad.0b013e318191c7dd</pub-id><pub-id pub-id-type="pmid">19474567</pub-id><pub-id pub-id-type="pmcid">PMC2743984</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Boulouis</surname><given-names>G.</given-names></name><name name-style="western"><surname>Charidimou</surname><given-names>A.</given-names></name><name name-style="western"><surname>Roongpiboonsopit</surname><given-names>D.</given-names></name><name name-style="western"><surname>Jessel</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Pasi</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Dementia incidence and predictors in cerebral amyloid angiopathy patients without intracerebral hemorrhage.</article-title><source><italic toggle="yes">J. Cereb. Blood Flow Metab.</italic></source><volume>38</volume><fpage>241</fpage>–<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1177/0271678x17700435</pub-id><pub-id pub-id-type="pmid">28318355</pub-id><pub-id pub-id-type="pmcid">PMC5951014</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yendiki</surname><given-names>A.</given-names></name><name name-style="western"><surname>Koldewyn</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kakunoori</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kanwisher</surname><given-names>N.</given-names></name><name name-style="western"><surname>Fischl</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Spurious group differences due to head motion in a diffusion MRI study.</article-title><source><italic toggle="yes">Neuroimage</italic></source><volume>88</volume><fpage>79</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2013.11.027</pub-id><pub-id pub-id-type="pmid">24269273</pub-id><pub-id pub-id-type="pmcid">PMC4029882</pub-id></mixed-citation></ref></ref-list></back></article>